US20010039039A1 - Methods for selectively isolating DNA using rolling circle amplification - Google Patents

Methods for selectively isolating DNA using rolling circle amplification Download PDF

Info

Publication number
US20010039039A1
US20010039039A1 US09/820,356 US82035601A US2001039039A1 US 20010039039 A1 US20010039039 A1 US 20010039039A1 US 82035601 A US82035601 A US 82035601A US 2001039039 A1 US2001039039 A1 US 2001039039A1
Authority
US
United States
Prior art keywords
dna
fragments
complementary
circle
polymerase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/820,356
Inventor
Sherman Weissman
Roger Lasken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/820,356 priority Critical patent/US20010039039A1/en
Publication of US20010039039A1 publication Critical patent/US20010039039A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855Ligating adaptors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Definitions

  • This invention relates to methods for amplifying DNA sequences, including those selected in genome mismatch scanning procedures, through the use of rolling circle DNA amplification. Methods of the invention are useful in genotyping, phase determination, polymorphism analyses, mismatch scanning procedures, and general cloning procedures.
  • Rolling circle amplification is an isothermal process for generating multiple copies of a sequence.
  • a DNA polymerase extends a primer on a circular template (Kornberg, A. and Baker, T. A. DNA Replication , W. H. Freeman, New York, 1991).
  • the product consists of tandemly linked copies of the complementary sequence of the template.
  • RCA is a method that has been adapted for use in vitro for DNA amplification (Fire, A. and Si-Qun Xu, Proc. Natl. Acad. Sci. USA, 1995, 92:46414645; Lui, D., et al., J. Am. Chem.
  • RCA can also be used in a detection method using a probe called a “padlock probe” (WO Pat. Ap. Pub. 95/22623 to Landegren; Nilsson, M., et al. Nature Genetics, 1997, 16:252-255, and Nilsson, M., and Landegren, U., in Landegren, U., ed., Laboratory Protocolsfor Mutation Detection , Oxford University Press, Oxford, 1996, pp. 135-138). DNA synthesis has been limited to rates ranging between 50 and 300 nucleotides per second (Lizardi, cited above and Lee, J., et al., Molecular Cell, 1998, 1:1001-1010).
  • DNA polymerase III holoenzyme also referred to herein as pol III
  • pol III DNA polymerase III holoenzyme which has an intrinsic catalytic rate of about 700-800 nucleotides per second
  • the invention also applies to subassemblies of the pol III holoenzyme which lack one or more of the subunits found in the complete, native enzyme complex (Kornberg and Baker, cited above).
  • the invention applies to DNA polymerase III holoenzyme derived from E.
  • DNA polymerases from eukaryotes that have clamp (PCNA) and clamp loader (RFC) components (Kornberg and Baker, cited above).
  • PCNA clamp
  • RRC clamp loader
  • pol I-like DNA polymerases are evolutionarily distinguished from pol I-type enzymes (Braithwaite, D. K., and Ito, J., Nuc. Acids Res., 1993, 21:787-802.) that have previously been employed in RCA (Fire and Xu, Lui, D. et al., Lizardi et al., and Lee et al., all cited above).
  • this invention introduces the novel use of a distinct class of DNA polymerases that have not previously been used in RCA.
  • the methods are appicable to polymorphism detection, diagnostics, phase determination, genotyping, genomic mapping, DNA sequencing, synthesis of DNA probes, or cloning.
  • the high rate of synthesis, great processivity, and ability to replicate through sequence obstructions give pol III an advantage over other DNA polymerases in RCA.
  • the E. coli dnab, dnaG, and dnaC proteins or other helicases and the single-stranded DNA binding protein (SSB) can also be used to facilitate the reaction (Kornberg and Baker, cited above).
  • This invention applies to the use of pol III with any accessory proteins including helicases, primases, and DNA binding proteins that facilitate the pol III reaction.
  • two or more DNA polymerases are combined in one RCA reaction.
  • One of the polymerases may have a 3′ ⁇ 5′ exonuclease activity capable of removing mismatched nucleotides.
  • Such combinations of DNA polymerases are known to increase primer extension. (Cheng, S. et al., Proc. Natl. Acad. Sci. USA, 1994, 91:5695-5699.)
  • This invention further provides for a method to produce approximately equimolar rolling circle amplification of DNA fragment mixtures.
  • the method is applicable to RCA of any DNA including for purposes of detection, cloning, generation of probes, genetic mismatch scanning (GMS) procedures, DNA mapping, sequencing, and genotyping.
  • GMS genetic mismatch scanning
  • a greater number of copies of shorter circles will be generated relative to longer circles. This effect is reduced by creating a “slow step” or “pause site” that occurs once each time the DNA polymerase copies around the circle. Therefore, the DNA polymerase rapidly copies around the circles and then it pauses for the slow step before copying around the circle again. The number of copies made of each circle will tend to be the same, independent of the length of the circle.
  • the pause site is created by the introduction of one or more abasic sites in the template.
  • DNA polymerases are slowed but not completely blocked by such a site. They will tend to insert a nucleotide opposite the abasic site (Randell, S. K., et al., J. Biol. Chem., 1987, 262:6864-6870).
  • DNA fragments selected with genomic mismatch scanning are amplified by RCA.
  • Nelson and associates described and employed GMS to directly identify identical-by-descent (IBD) sequences in yeast (Nelson, S.F., et al., Nature Genetics, 1993, 4:11-18).
  • the method allows DNA fragments from IBD regions between two relatives to be isolated based on their ability to form mismatch-free hybrid molecules.
  • the method consists of digesting DNA fragments from two sources with a restriction endonuclease that produces protruding 3′-ends.
  • the protruding 3′-ends provide some protection from exonuclease III (Exo III), which is used in later steps.
  • the two sources are distinguished by methylating the DNA from only one source. Molecules from both sources are denatured and reannealed, resulting in the formation of four types of duplex molecules: homohybrids formed from strands derived from the same source and heterohybrids consisting of DNA strands from different sources. Heterohybrids can either be mismatch-free or contain base-pair mismatches, depending on the extent of identity of homologous regions.
  • Homohybrids are distinguished from heterohybrids by use of restriction endonucleases that cleave fully methylated or unmethylated GATC sites. Homohybrids are cleaved into smaller duplex molecules. Heterohybrids containing a mismatch are distinguished from mismatch-free molecules by use of the E. coli methyl-directed mismatch repair system.
  • the combination of three proteins of the system MutS, MutL, and MutH (herein collectively called MutSLH) along with ATP introduce a single-strand nick on the unmethylated strand at GATC sites in duplexes that contain a mismatch (Welsh, et al., J. Biol.
  • Heterohybrids that do not contain a mismatch are not nicked. All molecules are then subjected to digestion by Exo III, which can initiate digestion at a nick, a blunt end, or a recessed 3′-end, to produce single-stranded gaps. Only mismatch-free heterohybrids are not subject to attack by Exo III; all other molecules have single-stranded gaps introduced by the enzyme. Molecules with single-stranded regions are removed by absorption to benzoylated napthoylated DEAE cellulose. The remaining molecules consist of mismatch-free heterohybrids which may represent regions of IBD.
  • Methods are given for isolating DNA containing nucleotide base mispairs using a modified rolling circle amplification procedure.
  • DNA fragments containing the base mismatches are nicked by conventional genomic mismatch scanning methods.
  • the 3′-OH at the nick serves as a primer for DNA synthesis.
  • the 3′-end is elongated by a DNA polymerase possessing strand displacement or nick translation capacity, or by a combination of a DNA polymerase capable of strand displacing at a nick and DNA polymerase m holoenzyme which provides a high rate of processive DNA synthesis.
  • DNA polymerase III holoenzyme (herein referred to as pol III or pol III holoenzyme) is used to provide a superior rate of DNA synthesis and also high processivity which allows rapid replication through regions of high GC content, hairpin structures and other regions of secondary structure, and regions that normally slow replication due to local sequence context effects.
  • coli dnab, dnaG, and dnaC gene products or other DNA helicases and the single-stranded DNA binding protein (SSB) are also used to improve the reaction.
  • the use of pol m or pol m combined with other replication proteins is generally applicable to any RCA procedure in addition to methods specifically relating to GMS procedures.
  • two DNA polymerases are combined together.
  • One of the polymerases has a 3′ ⁇ 5′ exonuclease activity capable of removing misincorporated nucleotides.
  • the “slow step” is created by introducing a site on the DNA sequence where the DNA polymerase is slowed or otherwise partially obstructed.
  • a slowing of the rate of DNA polymerization is typically created at so-called “pause sites” at naturally occurring sequences where the local DNA structure is unfavorable for replication, or by introducing abasic sites which require longer times for the insertion of nucleotides by the DNA polymerase.
  • pause sites at naturally occurring sequences where the local DNA structure is unfavorable for replication, or by introducing abasic sites which require longer times for the insertion of nucleotides by the DNA polymerase.
  • An alternative approach is to completely block the DNA polymerase with a reversible obstruction so that replication can be repeatedly stopped and then continued. For example, a properly designed hairpin structure can block replication at a low temperature while elevation to a higher temperature can be repeatedly used to allow the next cycle of DNA synthesis.
  • Methods are also given for determining the genetic phase of linked DNA markers by selective amplification of one parental haplotype.
  • Several procedures are given for cutting DNA to create the target fragment to be analyzed, and circularizing the target DNA.
  • Alternative procedures are also used to prime the DNA synthesis used for RCA.
  • By circularizing the target fragment with an adapter for which only one of its strands can be ligated a nick with a 3′-OH is created in the DNA circle that can serve as a primer for initiating rolling circle amplification.
  • an adapter which has an internal single-stranded region and which also has double-stranded ends with appropriate overhangs for ligation to the target DNA, a single-stranded gap is introduced into the circularized adapter-fragment construct. This gap can be employed as a site for primer annealing facilitating the initiation of rolling circle amplification.
  • the 3′-OH of the gap itself can also serve as a primer.
  • the single-stranded DNA product of rolling circle amplification can itself be replicated by annealing of complementary primers which can be extended in conventional primer elongation reactions or in hyberbranching reactions in which exponential amplification occurs (Lizardi, cited above).
  • primers with 3′-ends complementary to one of two alleles the DNA synthesis can be used for detection purposes.
  • DNA polymerase m or DNA pol III derived from E. coli or other bacteria, or analogous polymerase complexes from eukaryotic organisms that also have clamp and clamp loader components Kerman, Z., and O'Donnell, M., Annu. Rev. Biochem., 1995, 64:171-200, Bloom, L.
  • DNA pol III is used to provide a superior rate of DNA synthesis and also high processivity which allows rapid replication through regions of high GC content, hairpin structures and other regions of secondary structure, and regions that normally slow replication due to local sequence context effects.
  • DNA helicases such as the dnaB gene product and SSB of E. coli can be used to further improve rate and strand displacement.
  • DNA pol III The superior performance of DNA pol III to other DNA polymerases gives an advantage in any genotyping, DNA mapping, DNA sequencing, or cloning work in which large DNA fragments, 1 kb to greater than a megabase in length are used, and also for shorter fragments where rate or strand displacement is important.
  • RNA fragments into a form that can be utilized as RCA templates by ligation of hairpin forming adapters to the ends of the fragments.
  • the adapters have 3′ and 5′ ends that are complementary to each other such that they form stem and loop structures.
  • the stem portion of the hairpin structures create blunt or overhanging ends that allow the adapter to be ligated to the end of any DNA fragments having the appropriate end.
  • the fragments are converted to a circular form which can be utilized as the template for an RCA reaction.
  • the loop portion of the adapters provide a single-stranded region to which the RCA primer can be annealed.
  • Another invention uses two or more DNA polymerases in an RCA reaction. At least one of the DNA polymerases possesses a 3′ ⁇ 5′ exonuclease proofreading activity capable of correcting base mispairs. The removal of misincorporated bases allows for greater primer extension.
  • FIG. 1 Adapters are ligated to DNA fragments to obtain fragment-plus-adapter constructs (FIG. 1A); ligation products are shown in FIG. 1B; the adapter-fragment constructs are then subjected to nicking by the MutSLH proteins (FIG. 1C); the nicked fragments are subsequently subjected to a DNA polymerase reaction in which the 3′-OH at the nick is elongated (FIG. 1C and FIG. 1D); as a result of the adapters, the 3′-end of the extended strand (FIG.
  • a “splint oligonucleotide” can be used to circularize the DNA (FIG. 1E); if the DNA is circularized so that its two ends are brought together at a nick, then the ends can be ligated together by DNA ligase forming a covalently closed circle (FIG. 1F).
  • a partially double-strnaded adapter is used to circularize a double stranded DNA fragment for use as an RCA template. The adapter which has appropriate overhangs on its ends to allow ligation to both ends of the DNA fragment (FIG.
  • FIG. 1G can be used such that annealing of the ends results in a circularized adapter-fragment construct (FIG. 1H) and ligation seals the nicks (FIG. 1I); a single-stranded gap (FIG. 1G), or a nick, located in an internal region of the adapter, provides a 3′-OH (FIG. 1G) that can serve as a primer for DNA polymerase (FIG. 1J); the presence of a non-complementary 5′-tail (FIG. 1J) facilitates the initiation of strand displacement synthesis in which a DNA polymerase invades the duplex region of the DNA template (FIG. 1K).
  • An alternative method for copying a sequence of DNA in an RCA is to use a padlock DNA annealed to the target fragment (FIG. 1L) to create a single stranded gap; extension of the 3′-OH of the padlock DNA followed by ligation results in the circularization of the padlock which is linked to the target DNA (FIG. 1M); an RCA primer is annealed to the padlock DNA (FIG. 1N) for the priming of DNA synthesis; the RCA primer can have a non-complementary 5′-tail that facilitates the initiation of strand-displacement at a nick (FIG. 1N).
  • FIG. 2 shows the use of adapters to convert DNA fragments into a form that can be utilized as rolling circle amplification templates by ligation of hairpin forming adapters to the ends of the fragments.
  • the adapters contain self-complementary sequences at their 3′ and 5′ ends such that they form stem and loop structures. Furthermore, the stem portion of the hairpin structures create blunt or overhanging ends that allow the adapter to be ligated to the end of any DNA fragments having the appropriate end. By ligating such adapters to both ends of the DNA fragments, the fragments are converted to a circular form which can be utilized as the template for an RCA reaction. Also, the loop portion of the adapters provide a single-stranded region to which the RCA primer can be annealed.
  • FIG. 3 shows the effect of dNTP concentration and T7 native DNA polymerase on rolling circle amplification by SEQUENASETM.
  • FIG. 4 shows the effect of mismatch correction by T7 native DNA polymerase on rolling circle amplification by SEQUENASETM.
  • FIG. 5 shows product formed using DNA polymerase m holoenzyme and primed M13 single-stranded DNA as the template.
  • the product strands are larger than 12 kb (see the arrow for ( ⁇ ) EcoR I).
  • the reaction products were digested with EcoR 1 which converted the product DNA to unit lengths of 7250 kb (FIG. 3, (+) EcoRI).
  • This invention provides for the amplification of specific DNA sequences by RCA.
  • heterohybrid DNA is treated using GMS (Nelson, et al., cited above and U.S. Pat. No. 5,556,750 to Modrich, et al.).
  • GMS Nelon, et al., cited above and U.S. Pat. No. 5,556,750 to Modrich, et al.
  • the procedure allows for the MutSLH nicking of DNA fragments containing mismatched bases as a means to analyze polymorphism between DNA samples.
  • An improved method for utilizing the MutSLH-generated nick in a DNA amplification strategy is provided here in which the 3′-OH at the nick is used as a primer for a DNA polymerase.
  • the DNA polymerase must replicate a double-stranded DNA template in such a reaction.
  • DNA pol III can be used for this step as can other DNA polymerases, some of which have greater ability than pol III to initiate strand displacement at a nick.
  • Two or more DNA polymerases can also be combined in order to take advantages of each polymerase. In the case where one of the poymerases has a 3′ ⁇ 5′ exonuclease activity, the reaction is improved by the removal of misincorporated nucleotides.
  • At least one DNA sample is methylated and a second DNA sample is not methylated.
  • the samples are then cut with a restriction endonuclease such as Pvu1, mixed together, denatured and then reannealed to form heterohybrid DNA.
  • Any DNA sample may be subjected to the methods of the invention including genomic DNA, genomic fragments, cDNA, cDNA fragments, and mixtures of these.
  • Adapters are then ligated to the fragments to obtain fragment-plus-adapter constructs (FIG. 1A).
  • Linear or Y-shaped adapters may be employed.
  • Y-shaped adapters (FIG. 1A) are used in many preferred embodiments, but, in some cases, where Y-shaped adapters are illustrated, the methods can also be adapted to conventional linear adapters.
  • Y-shaped adapters have been described (see Prashar, Y., and Weissman, S., Proc. Natl. Acad Sci. USA, 1996, 93:659-663).
  • a Y-shaped adapter typically has an overhang at one end for ligation to a DNA fragment, and, at the other end, a stretch of noncomplementary sequence on the opposite strands, giving rise to its Y-shape. It is an advantage of the invention that, in preferred embodiments, the Y-shaped adapters allow for the synthesis of non-overlapping subsets of DNA. In typical embodiments, if the invention is carried out with conventional, linear primers, then the PCR-generated subsets will be partially overlapping, that is, some DNA sequences will be represented in more than one subset. It is another advantage of the invention that Y-shaped adapters allow for the synthesis of a DNA fragment of unique sequence by using a GMS generated nick as a primer as described below.
  • the adapter-fragment constructs are then subjected to nicking by the MutSLH proteins (FIG. 1C).
  • the nicked fragments are subsequently subjected to a DNA polymerase reaction in which the 3′-OH at the nick is elongated (FIG. 1C and D).
  • the 3′-end of the extended strand (FIG. 1D, c′) will be complementary to the Y-region of the other strand. Therefore, all DNAs nicked by MutSLH and subjected to elongation of the 3′-OH can be selected for by the unique combination of sequences at the ends.
  • a “splint oligonucleotide” is designed for purposes of circularizing the DNA (FIG. 1E).
  • a “splint oligonucleotide” is a single-stranded sequence complementary to the ends of the DNA that results from extension of the nick (FIG. 1D) such that denaturation of the DNA and annealing of the splint to the extended strand circularizes it. If the DNA is circularized so that its two ends are brought together at a nick, then the ends can be ligated together by DNA ligase forming a covalently closed circle (FIG. 1F).
  • This DNA can then be amplified in an RCA either by extension of the 3′-OH of the splint or by annealing of another primer to the circularized DNA (FIG. 1F).
  • Either the splint or another primer can have a region of DNA sequence at its 5′-end that is not complementary to the template (FIG. 1E) and, therefore, can facilitate initiation of RCA (FIG. 1F). This is because, following extension of the primer once around the DNA template, the non-complementary 5′-end of the primer sequence allows easier invasion of the duplex template by the polymerase. (See reviews by Hingorani, M. M., and O'Donnell, M., Current Biology, 1998, 8:R83-86 and by Kelman, Z., et al., cited above).
  • DNA polymerase III holoenzyme derived from E. coli or other bacteria including gram-positive and gram-negative bacteria, or related DNA polymerases from eukaryotes that have clamp and clamp loader components (Kornberg and Baker and Kelman and O'Donnell, cited above) can be employed as the DNA polymerase in RCA.
  • Use of DNA pol III in preferred embodiments provides a greater rate and processivity than other DNA polymerases and provides superior yield and ability to replicate long templates and templates having obstructions to DNA replication such as high GC content, or unfavorable secondary structure or sequence context.
  • Two or more DNA polymerases can also be combined in order to take advantages of each of polymerase's properties.
  • the E. coli dnaB and dnaC proteins or other helicases and the single-stranded DNA binding protein (SSB) can also be used to improve rate and strand displacement (Kornberg and Baker, cited above).
  • this invention also advantageously provides methods for producing approximately equimolar rolling circle amplification of DNA fragment mixtures.
  • the methods are applicable to RCA of any DNA including for purposes of detection, cloning, generation of probes, GMS procedures, DNA mapping, sequencing, and genotyping.
  • a pause site is created by the introduction of one or more abasic sites in the template. DNA polymerases are slowed but not completely blocked by such a site. They will tend to insert a nucleotide opposite the abasic site (Randell, cited above).
  • the pause site can be introduced into the template by standard procedures for ligating a fragment containing the pause site into a double-stranded DNA.
  • Another approach is to circularize a single-strand DNA target fragment with a splint that contains the pause site in a double-stranded internal segment and that has single-stranded ends complementary to the ends of the target fragment. Ligation of this construct results in the insertion of the abasic sequence into the target fragment.
  • Another method is to insert a sequence containing one or more uracils as bases and then creating abasic sites by treatment with uracil glycosylase (UDG, Kornberg and Baker, cited above). The method is also applicable for other types of pause sites such as hairpin structures or protein binding sites on the DNA.
  • an adapter that allows for circularization of the fragment and subsequent RCA
  • the adapter has appropriate overhangs on its ends to allow ligation to both ends of the DNA fragment (FIG. 1G) such that annealing of the ends results in a circularized adapter-fragment construct (FIG. 1H) and ligation seals the nicks (FIG. 11).
  • the adapter also provides for the ability to prime RCA.
  • a single-stranded gap (FIG. 1G), or a nick, located in an internal region of the adapter provides a 3′-OH (FIG. 1G) that can serve as a primer for DNA polymerase (FIG. 1J).
  • FIG. 1J The presence of a non-complementary 5′-tail (FIG. 1J) facilitates the initiation of strand displacement synthesis in which a DNA polymerase invades the duplex region of the DNA template (FIG. 1K).
  • Embodiments of this invention employ DNA pol III to improve the rate and processivity of the RCA.
  • a method for the use of DNA polymerase III for RCA using the padlock method is also given for the use of DNA polymerase III for RCA using the padlock method (Nilsson, M., et al., cited above).
  • the padlock DNA is annealed to the target fragment (FIG. 1L) a single stranded gap is created.
  • Extension of the 3′-OH of the padlock DNA followed by ligation results in the circularization of the padlock which is linked to the target DNA (FIG. 1M).
  • FOG. 1M target DNA
  • An advantage of this invention is that use DNA polymerase III in the extension step allows for a larger single-stranded gap length because of its superior rate and processivity.
  • pot III provides greater rates and yields.
  • Another advantage of pol III is that it has very slow rates of initiating strand displacement at a nick compared to other DNA polymerases (O'Donnell, M., and Kornberg, A., J. Biol. Chem., 1985, 260:12884). Therefore, pol III will tend not to displace the 5′-end of the padlock DNA prior to ligation.
  • an RCA primer is annealed to the padlock DNA (FIG. 1N) for the priming of DNA synthesis.
  • Pol III is also employed for this reaction because of advantages in RCA mentioned above.
  • the RCA primer can have a non-complementary 5′-tail that facilitates the initiation of strand displacement at a nick (FIG. 1N).
  • DNA pot III provides superior rates and processivity for strand displacement synthesis.
  • a general method is also given for polymorphism analysis of repeat sequences such as di- and tri-nucleotide repeats and other microsatellite sequences which are frequently used because of their high level of polymorphism.
  • repeat sequences such as di- and tri-nucleotide repeats and other microsatellite sequences which are frequently used because of their high level of polymorphism.
  • RCA is a linear amplification in which the same DNA template is repeatedly copied, replication errors do not accumulate exponentially as they do in a PCR in which the product DNA of one cycle can serve as the template in a subsequent cycle.
  • the use of DNA polymerase III in the reaction reduces the errors because of the highly processive synthesis and fidelity of the enzyme (Kornberg and Baker, cited above).
  • kits are given for converting DNA fragments into a form that can be utilized as RCA templates by ligation of hairpin forming adapters to the ends of the fragments (FIG. 2).
  • the adapters contain self-complementary sequences at their 3′ and 5′ ends such that they form stem and loop structures. Furthermore, the stem portion of the hairpin structures create blunt or overhanging ends that allow the adapter to be ligated to the end of any DNA fragments having the appropriate end.
  • the fragments are converted to a circular form which can be utilized as the template for an RCA reaction.
  • the loop portion of the adapters provide a single-stranded region to which the RCA primer can be annealed.
  • the constructs formed can be amplified in an RCA using a primer complementary to the adapters.
  • the method allows for a whole genome amplification in which a subset of DNA segments derived from the original DNA sample are amplified.
  • Another invention uses two or more DNA polymerases in an RCA reaction. At least one of the DNA polymerases possesses a 3′ ⁇ 5′ exonuclease proofreading activity capable of correcting base mispairs. The removal of misincorporated bases allows for greater primer extension.
  • RCA reactions were performed at 37° C. and aliquots were removed at 1, 2, and 3 hours, as indicated, in a reaction volume of 50 microliters containing 20 mM Tris-acetate, 10 mM magnesium acetate, and 50 mM potassium acetate, pH 7.9@25° C., 0.2 mM or 1.0 mM each deoxynucleoside triphosphate, as indicated, 2 uCi 5′-[- 32 P] dCTP (Amersham Pharmacia Biotech), 30 ng of M13 singly-primed single-stranded M13 DNA (see below), 4.2 micrograms of E.coli single-strand DNA binding protein (Studwell & O'Donnell, J. Biol. Chem.
  • Primer F4 (5′-TCT GTT TAT AGG GCC TCT TCG CTA TTA CGC CAG C-3′) consisted of 24 nucleotides at the 3′ end complementary to M13mp19 (+) strand, and 10 nucleotides non-complementary at the 5′ end. The 3′ end is at M13 map position 6377.
  • This example shows the dependence on T7 DNA polymerase concentration of the stimulation of RCA reactions using sequenase (FIG. 4). RCA reactions were performed for 3 hr as described in Example 1 except that T7 native polymerase was added as indicated. Aliquots (4ul) were spotted onto DE81 filter paper and deoxynucleotide incorporation was determined.
  • RCA Rolling Circle Amplification Assay using reconstituted DNA polymerase III holoenzyme (Kelman and O'Donnell, Annu. Rev. Biochem. 64: 171-200, 1995), and accessory replication proteins including DnaB helicase (Arai et al., J. Biol. Chem. 256: 5247-5252, 1981), DnaG primase (Rowen and Kornberg, J. Biol. Chem. 253: 758-764, 1978) and SSB (Studwell and O'Donnell, J. Biol. Chem. 265: 1175-1178, 1990).
  • This example demonstrates the product formed using DNA polymerase III holoenzyme and primed M13 single-stranded DNA as the template.
  • the product strands are larger than 12 kb (see the arrow in FIG. 5, for ( ⁇ ) EcoR I).
  • the reaction products were digested with EcoR 1 which converted the product DNA to unit lengths of 7250 kb (FIG. 3, (+) EcoR1).
  • RCA assays were in 50 ⁇ l of Reaction buffer (HEPES-NaOH (pH7.4), 12 mM MgCl 2 , 5 mM DTT, 100 ⁇ g BSA/ml, 5 mM ATP, 20% Glycerol (v/v)) containing 325 ng (138 fmol) M13mp19 (+) ssDNA as template, 2.5 pmol of F4 primer (5′-TCT GTT TAT AGG GCC TCT TCG CTA TTA CGC CAG C-3′, the underlined sequence annealed to position 6377-6400 on M13mp19 (+) strand), 1.25 pmol (as dimer) of ⁇ clamp, 1 pmol of Pol III*, 5.5 pmol (as hexamer) of DnaB (helicase), 15.4 pmol of DnaG (primase), 54.2 pmol (as tetramer) of SSB, 50 n
  • the primer or DNA fragment is tagged with biotin or the like and captured with strepavidin or avidin or the like using standard procedures (Geschwind, D. H., et al., Genetic Analysis, 1996, 13:105-111). Selective cleavage of DNA using RecA-assisted restriction endonuclease (RARE) may be employed (Ferrin, L.
  • RARE RecA-assisted restriction endonuclease
  • DNA Artificial Sequence 24 nucleotides at the 3′ end complementary to M13mp19(+) (at map position 6377) and 10 nucleotides non-complementary at the 5′ end 1 tctgtttata gggcctcttc gctattacgc cagc 34

Abstract

DNA containing nucleotide base mispairs can be isolated using a modified rolling circle amplification procedure. Specific Y-shaped adapters permit the selective circularization of these fragments with a complementary splint oligonucleotide. Rolling circle amplification is then carried out with a DNA polymerase. Rolling circle amplification can also be carried out using a mixture of DNA circles having different lengths. Genetic phase of linked DNA markers can be determined by selective amplification of one parental haplotype. DNA fragments can also be converted into a form that can be utilized as rolling circle amplification templates by ligation of hairpin forming adapters to the ends of the fragments. Two or more DNA polymerases can be used in a rolling circle amplification reaction. DNA polymerase III has special properties that improve rolling circle amplification.

Description

  • This application claims the benefit of application Ser. No. 60/100,996 filed Sep. 18, 1998.[0001]
  • TECHNICAL FIELD OF THE INVENTION
  • This invention relates to methods for amplifying DNA sequences, including those selected in genome mismatch scanning procedures, through the use of rolling circle DNA amplification. Methods of the invention are useful in genotyping, phase determination, polymorphism analyses, mismatch scanning procedures, and general cloning procedures. [0002]
  • BACKGROUND OF THE INVENTION
  • Rolling circle amplification (RCA) is an isothermal process for generating multiple copies of a sequence. In rolling circle DNA replication in vivo, a DNA polymerase extends a primer on a circular template (Kornberg, A. and Baker, T. A. [0003] DNA Replication, W. H. Freeman, New York, 1991). The product consists of tandemly linked copies of the complementary sequence of the template. RCA is a method that has been adapted for use in vitro for DNA amplification (Fire, A. and Si-Qun Xu, Proc. Natl. Acad. Sci. USA, 1995, 92:46414645; Lui, D., et al., J. Am. Chem. Soc., 1996,118:1587-1594; Lizardi, P. M., et al., Nature Genetics, 1998, 19:225-232; U.S. Pat. No.5,714,320 to Kool). RCA can also be used in a detection method using a probe called a “padlock probe” (WO Pat. Ap. Pub. 95/22623 to Landegren; Nilsson, M., et al. Nature Genetics, 1997, 16:252-255, and Nilsson, M., and Landegren, U., in Landegren, U., ed., Laboratory Protocolsfor Mutation Detection, Oxford University Press, Oxford, 1996, pp. 135-138). DNA synthesis has been limited to rates ranging between 50 and 300 nucleotides per second (Lizardi, cited above and Lee, J., et al., Molecular Cell, 1998, 1:1001-1010).
  • In some embodiments of this invention, increased rates of DNA synthesis in RCA are achieved by the use of DNA polymerase III holoenzyme (also referred to herein as pol III) which has an intrinsic catalytic rate of about 700-800 nucleotides per second (Kornberg and Baker, cited above). The invention also applies to subassemblies of the pol III holoenzyme which lack one or more of the subunits found in the complete, native enzyme complex (Kornberg and Baker, cited above). The invention applies to DNA polymerase III holoenzyme derived from [0004] E. coli and also other bacteria, including gram-positive and gram-negative bacteria, or related DNA polymerases from eukaryotes that have clamp (PCNA) and clamp loader (RFC) components (Kornberg and Baker, cited above). These pol I-like DNA polymerases are evolutionarily distinguished from pol I-type enzymes (Braithwaite, D. K., and Ito, J., Nuc. Acids Res., 1993, 21:787-802.) that have previously been employed in RCA (Fire and Xu, Lui, D. et al., Lizardi et al., and Lee et al., all cited above).
  • Therefore, this invention introduces the novel use of a distinct class of DNA polymerases that have not previously been used in RCA. The methods are appicable to polymorphism detection, diagnostics, phase determination, genotyping, genomic mapping, DNA sequencing, synthesis of DNA probes, or cloning. The high rate of synthesis, great processivity, and ability to replicate through sequence obstructions give pol III an advantage over other DNA polymerases in RCA. The [0005] E. coli dnab, dnaG, and dnaC proteins or other helicases and the single-stranded DNA binding protein (SSB) can also be used to facilitate the reaction (Kornberg and Baker, cited above). This invention applies to the use of pol III with any accessory proteins including helicases, primases, and DNA binding proteins that facilitate the pol III reaction.
  • In another embodiment of the invention two or more DNA polymerases are combined in one RCA reaction. One of the polymerases may have a 3′→5′ exonuclease activity capable of removing mismatched nucleotides. Such combinations of DNA polymerases are known to increase primer extension. (Cheng, S. et al., Proc. Natl. Acad. Sci. USA, 1994, 91:5695-5699.) [0006]
  • This invention further provides for a method to produce approximately equimolar rolling circle amplification of DNA fragment mixtures. The method is applicable to RCA of any DNA including for purposes of detection, cloning, generation of probes, genetic mismatch scanning (GMS) procedures, DNA mapping, sequencing, and genotyping. In an RCA using mixed circular DNA templates of different length, a greater number of copies of shorter circles will be generated relative to longer circles. This effect is reduced by creating a “slow step” or “pause site” that occurs once each time the DNA polymerase copies around the circle. Therefore, the DNA polymerase rapidly copies around the circles and then it pauses for the slow step before copying around the circle again. The number of copies made of each circle will tend to be the same, independent of the length of the circle. In one procedure, the pause site is created by the introduction of one or more abasic sites in the template. DNA polymerases are slowed but not completely blocked by such a site. They will tend to insert a nucleotide opposite the abasic site (Randell, S. K., et al., [0007] J. Biol. Chem., 1987, 262:6864-6870).
  • In one embodiment of this invention, DNA fragments selected with genomic mismatch scanning are amplified by RCA. In 1993 Nelson and associates described and employed GMS to directly identify identical-by-descent (IBD) sequences in yeast (Nelson, S.F., et al., [0008] Nature Genetics, 1993, 4:11-18). The method allows DNA fragments from IBD regions between two relatives to be isolated based on their ability to form mismatch-free hybrid molecules. The method consists of digesting DNA fragments from two sources with a restriction endonuclease that produces protruding 3′-ends. The protruding 3′-ends provide some protection from exonuclease III (Exo III), which is used in later steps. The two sources are distinguished by methylating the DNA from only one source. Molecules from both sources are denatured and reannealed, resulting in the formation of four types of duplex molecules: homohybrids formed from strands derived from the same source and heterohybrids consisting of DNA strands from different sources. Heterohybrids can either be mismatch-free or contain base-pair mismatches, depending on the extent of identity of homologous regions.
  • Homohybrids are distinguished from heterohybrids by use of restriction endonucleases that cleave fully methylated or unmethylated GATC sites. Homohybrids are cleaved into smaller duplex molecules. Heterohybrids containing a mismatch are distinguished from mismatch-free molecules by use of the [0009] E. coli methyl-directed mismatch repair system. The combination of three proteins of the system MutS, MutL, and MutH (herein collectively called MutSLH) along with ATP introduce a single-strand nick on the unmethylated strand at GATC sites in duplexes that contain a mismatch (Welsh, et al., J. Biol. Chem., 1987, 262:15624). Heterohybrids that do not contain a mismatch are not nicked. All molecules are then subjected to digestion by Exo III, which can initiate digestion at a nick, a blunt end, or a recessed 3′-end, to produce single-stranded gaps. Only mismatch-free heterohybrids are not subject to attack by Exo III; all other molecules have single-stranded gaps introduced by the enzyme. Molecules with single-stranded regions are removed by absorption to benzoylated napthoylated DEAE cellulose. The remaining molecules consist of mismatch-free heterohybrids which may represent regions of IBD.
  • SUMMARY OF THE INVENTION
  • Methods are given for isolating DNA containing nucleotide base mispairs using a modified rolling circle amplification procedure. DNA fragments containing the base mismatches are nicked by conventional genomic mismatch scanning methods. The 3′-OH at the nick serves as a primer for DNA synthesis. The 3′-end is elongated by a DNA polymerase possessing strand displacement or nick translation capacity, or by a combination of a DNA polymerase capable of strand displacing at a nick and DNA polymerase m holoenzyme which provides a high rate of processive DNA synthesis. Specific Y-shaped adapters attached to the ends of the fragments are designed such that DNA products generated by the extension of the 3′-OH at the nick have a unique sequence at their 3′-end. The unique sequences allow for the selective circularization of these fragments with a complementary splint oligonucleotide. Rolling circle amplification is then carried out with a DNA polymerase. DNA polymerase III holoenzyme (herein referred to as pol III or pol III holoenzyme) is used to provide a superior rate of DNA synthesis and also high processivity which allows rapid replication through regions of high GC content, hairpin structures and other regions of secondary structure, and regions that normally slow replication due to local sequence context effects. The [0010] E. coli dnab, dnaG, and dnaC gene products or other DNA helicases and the single-stranded DNA binding protein (SSB) are also used to improve the reaction. The use of pol m or pol m combined with other replication proteins is generally applicable to any RCA procedure in addition to methods specifically relating to GMS procedures. In another method that improves any RCA reaction in general, two DNA polymerases are combined together. One of the polymerases has a 3′→5′ exonuclease activity capable of removing misincorporated nucleotides.
  • In addition, methods are given for carrying out rolling circle amplification of a mixture of DNA circles having different lengths. In general, more copies will tend to be made for shorter circles because the DNA polymerase requires less time to replicate them. For some procedures, including the amplification of DNA for cloning or detection purposes, or for genomic mismatch scanning, it is desirable to produce approximately equal numbers of all circles independent of their length. This is accomplished by creating a slow step in the replication process. Therefore, replication stops for a period of time once each time the DNA polymerase copies around the circle. The result of having one slow step for each copy of the circle that is synthesized is that the rate-limiting step for the amplification tends to be the same regardless of the length of the circle. This tends to minimize the disparity between the number of copies made for circles of different length. The “slow step” is created by introducing a site on the DNA sequence where the DNA polymerase is slowed or otherwise partially obstructed. A slowing of the rate of DNA polymerization is typically created at so-called “pause sites” at naturally occurring sequences where the local DNA structure is unfavorable for replication, or by introducing abasic sites which require longer times for the insertion of nucleotides by the DNA polymerase. Several types of potential pause sites are described herein. An alternative approach is to completely block the DNA polymerase with a reversible obstruction so that replication can be repeatedly stopped and then continued. For example, a properly designed hairpin structure can block replication at a low temperature while elevation to a higher temperature can be repeatedly used to allow the next cycle of DNA synthesis. [0011]
  • Methods are also given for determining the genetic phase of linked DNA markers by selective amplification of one parental haplotype. Several procedures are given for cutting DNA to create the target fragment to be analyzed, and circularizing the target DNA. Alternative procedures are also used to prime the DNA synthesis used for RCA. By circularizing the target fragment with an adapter for which only one of its strands can be ligated, a nick with a 3′-OH is created in the DNA circle that can serve as a primer for initiating rolling circle amplification. By using an adapter which has an internal single-stranded region and which also has double-stranded ends with appropriate overhangs for ligation to the target DNA, a single-stranded gap is introduced into the circularized adapter-fragment construct. This gap can be employed as a site for primer annealing facilitating the initiation of rolling circle amplification. The 3′-OH of the gap itself can also serve as a primer. [0012]
  • The single-stranded DNA product of rolling circle amplification can itself be replicated by annealing of complementary primers which can be extended in conventional primer elongation reactions or in hyberbranching reactions in which exponential amplification occurs (Lizardi, cited above). By choosing primers with 3′-ends complementary to one of two alleles, the DNA synthesis can be used for detection purposes. DNA polymerase m or DNA pol III derived from [0013] E. coli or other bacteria, or analogous polymerase complexes from eukaryotic organisms that also have clamp and clamp loader components (Kelman, Z., and O'Donnell, M., Annu. Rev. Biochem., 1995, 64:171-200, Bloom, L. B., et al., J. Biol. Chem., 1997, 272:27919-27930, and Kelman, Z., et al., Structure, 1998, 6:121-125) are used to facilitate amplification of DNA targets including large fragments that are difficult to replicate with other enzymes. DNA pol III is used to provide a superior rate of DNA synthesis and also high processivity which allows rapid replication through regions of high GC content, hairpin structures and other regions of secondary structure, and regions that normally slow replication due to local sequence context effects. DNA helicases such as the dnaB gene product and SSB of E. coli can be used to further improve rate and strand displacement. The superior performance of DNA pol III to other DNA polymerases gives an advantage in any genotyping, DNA mapping, DNA sequencing, or cloning work in which large DNA fragments, 1 kb to greater than a megabase in length are used, and also for shorter fragments where rate or strand displacement is important.
  • In addition, methods are given for converting DNA fragments into a form that can be utilized as RCA templates by ligation of hairpin forming adapters to the ends of the fragments. The adapters have 3′ and 5′ ends that are complementary to each other such that they form stem and loop structures. Furthermore, the stem portion of the hairpin structures create blunt or overhanging ends that allow the adapter to be ligated to the end of any DNA fragments having the appropriate end. By ligating such adapters to both ends of the DNA fragments, the fragments are converted to a circular form which can be utilized as the template for an RCA reaction. Also, the loop portion of the adapters provide a single-stranded region to which the RCA primer can be annealed. [0014]
  • Another invention uses two or more DNA polymerases in an RCA reaction. At least one of the DNA polymerases possesses a 3′→5′ exonuclease proofreading activity capable of correcting base mispairs. The removal of misincorporated bases allows for greater primer extension.[0015]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 Adapters are ligated to DNA fragments to obtain fragment-plus-adapter constructs (FIG. 1A); ligation products are shown in FIG. 1B; the adapter-fragment constructs are then subjected to nicking by the MutSLH proteins (FIG. 1C); the nicked fragments are subsequently subjected to a DNA polymerase reaction in which the 3′-OH at the nick is elongated (FIG. 1C and FIG. 1D); as a result of the adapters, the 3′-end of the extended strand (FIG. 1D, c′) will be complementary to the Y-region of the other strand; a “splint oligonucleotide” can be used to circularize the DNA (FIG. 1E); if the DNA is circularized so that its two ends are brought together at a nick, then the ends can be ligated together by DNA ligase forming a covalently closed circle (FIG. 1F). A partially double-strnaded adapter is used to circularize a double stranded DNA fragment for use as an RCA template. The adapter which has appropriate overhangs on its ends to allow ligation to both ends of the DNA fragment (FIG. 1G) can be used such that annealing of the ends results in a circularized adapter-fragment construct (FIG. 1H) and ligation seals the nicks (FIG. 1I); a single-stranded gap (FIG. 1G), or a nick, located in an internal region of the adapter, provides a 3′-OH (FIG. 1G) that can serve as a primer for DNA polymerase (FIG. 1J); the presence of a non-complementary 5′-tail (FIG. 1J) facilitates the initiation of strand displacement synthesis in which a DNA polymerase invades the duplex region of the DNA template (FIG. 1K). An alternative method for copying a sequence of DNA in an RCA is to use a padlock DNA annealed to the target fragment (FIG. 1L) to create a single stranded gap; extension of the 3′-OH of the padlock DNA followed by ligation results in the circularization of the padlock which is linked to the target DNA (FIG. 1M); an RCA primer is annealed to the padlock DNA (FIG. 1N) for the priming of DNA synthesis; the RCA primer can have a non-complementary 5′-tail that facilitates the initiation of strand-displacement at a nick (FIG. 1N). [0016]
  • FIG. 2 shows the use of adapters to convert DNA fragments into a form that can be utilized as rolling circle amplification templates by ligation of hairpin forming adapters to the ends of the fragments. The adapters contain self-complementary sequences at their 3′ and 5′ ends such that they form stem and loop structures. Furthermore, the stem portion of the hairpin structures create blunt or overhanging ends that allow the adapter to be ligated to the end of any DNA fragments having the appropriate end. By ligating such adapters to both ends of the DNA fragments, the fragments are converted to a circular form which can be utilized as the template for an RCA reaction. Also, the loop portion of the adapters provide a single-stranded region to which the RCA primer can be annealed. [0017]
  • FIG. 3 shows the effect of dNTP concentration and T7 native DNA polymerase on rolling circle amplification by SEQUENASE™. [0018]
  • FIG. 4 shows the effect of mismatch correction by T7 native DNA polymerase on rolling circle amplification by SEQUENASE™. [0019]
  • FIG. 5 shows product formed using DNA polymerase m holoenzyme and primed M13 single-stranded DNA as the template. The product strands are larger than 12 kb (see the arrow for (−) EcoR I). To prove that the product DNA consisted of tandem repeats of the M13 sequence, as predicted for an RCA reaction, the reaction products were digested with [0020] EcoR 1 which converted the product DNA to unit lengths of 7250 kb (FIG. 3, (+) EcoRI).
  • DETAILED DESCRIPTION OF THE INVENTION
  • This invention provides for the amplification of specific DNA sequences by RCA. In one embodiment, heterohybrid DNA is treated using GMS (Nelson, et al., cited above and U.S. Pat. No. 5,556,750 to Modrich, et al.). The procedure allows for the MutSLH nicking of DNA fragments containing mismatched bases as a means to analyze polymorphism between DNA samples. An improved method for utilizing the MutSLH-generated nick in a DNA amplification strategy is provided here in which the 3′-OH at the nick is used as a primer for a DNA polymerase. The DNA polymerase must replicate a double-stranded DNA template in such a reaction. Therefore it must have strand displacing capability in which it can extend the 3′-OH end of the nick while melting the downstream double-stranded template. DNA pol III can be used for this step as can other DNA polymerases, some of which have greater ability than pol III to initiate strand displacement at a nick. Two or more DNA polymerases can also be combined in order to take advantages of each polymerase. In the case where one of the poymerases has a 3′→5′ exonuclease activity, the reaction is improved by the removal of misincorporated nucleotides. [0021]
  • In a typical practice of a method of the invention, at least one DNA sample is methylated and a second DNA sample is not methylated. The samples are then cut with a restriction endonuclease such as Pvu1, mixed together, denatured and then reannealed to form heterohybrid DNA. Any DNA sample may be subjected to the methods of the invention including genomic DNA, genomic fragments, cDNA, cDNA fragments, and mixtures of these. [0022]
  • Adapters are then ligated to the fragments to obtain fragment-plus-adapter constructs (FIG. 1A). Linear or Y-shaped adapters may be employed. Y-shaped adapters (FIG. 1A) are used in many preferred embodiments, but, in some cases, where Y-shaped adapters are illustrated, the methods can also be adapted to conventional linear adapters. Y-shaped adapters have been described (see Prashar, Y., and Weissman, S., [0023] Proc. Natl. Acad Sci. USA, 1996, 93:659-663). A Y-shaped adapter typically has an overhang at one end for ligation to a DNA fragment, and, at the other end, a stretch of noncomplementary sequence on the opposite strands, giving rise to its Y-shape. It is an advantage of the invention that, in preferred embodiments, the Y-shaped adapters allow for the synthesis of non-overlapping subsets of DNA. In typical embodiments, if the invention is carried out with conventional, linear primers, then the PCR-generated subsets will be partially overlapping, that is, some DNA sequences will be represented in more than one subset. It is another advantage of the invention that Y-shaped adapters allow for the synthesis of a DNA fragment of unique sequence by using a GMS generated nick as a primer as described below.
  • The adapter-fragment constructs are then subjected to nicking by the MutSLH proteins (FIG. 1C). The nicked fragments are subsequently subjected to a DNA polymerase reaction in which the 3′-OH at the nick is elongated (FIG. 1C and D). As a result of the adapters, the 3′-end of the extended strand (FIG. 1D, c′) will be complementary to the Y-region of the other strand. Therefore, all DNAs nicked by MutSLH and subjected to elongation of the 3′-OH can be selected for by the unique combination of sequences at the ends. [0024]
  • In some embodiments, a “splint oligonucleotide” is designed for purposes of circularizing the DNA (FIG. 1E). A “splint oligonucleotide” is a single-stranded sequence complementary to the ends of the DNA that results from extension of the nick (FIG. 1D) such that denaturation of the DNA and annealing of the splint to the extended strand circularizes it. If the DNA is circularized so that its two ends are brought together at a nick, then the ends can be ligated together by DNA ligase forming a covalently closed circle (FIG. 1F). This DNA can then be amplified in an RCA either by extension of the 3′-OH of the splint or by annealing of another primer to the circularized DNA (FIG. 1F). Either the splint or another primer can have a region of DNA sequence at its 5′-end that is not complementary to the template (FIG. 1E) and, therefore, can facilitate initiation of RCA (FIG. 1F). This is because, following extension of the primer once around the DNA template, the [0025] non-complementary 5′-end of the primer sequence allows easier invasion of the duplex template by the polymerase. (See reviews by Hingorani, M. M., and O'Donnell, M., Current Biology, 1998, 8:R83-86 and by Kelman, Z., et al., cited above).
  • Another aspect of this invention is that embodiments using DNA polymerase III holoenzyme derived from [0026] E. coli or other bacteria, including gram-positive and gram-negative bacteria, or related DNA polymerases from eukaryotes that have clamp and clamp loader components (Kornberg and Baker and Kelman and O'Donnell, cited above) can be employed as the DNA polymerase in RCA. Use of DNA pol III in preferred embodiments provides a greater rate and processivity than other DNA polymerases and provides superior yield and ability to replicate long templates and templates having obstructions to DNA replication such as high GC content, or unfavorable secondary structure or sequence context. Two or more DNA polymerases, including DNA pol III, can also be combined in order to take advantages of each of polymerase's properties. The E. coli dnaB and dnaC proteins or other helicases and the single-stranded DNA binding protein (SSB) can also be used to improve rate and strand displacement (Kornberg and Baker, cited above).
  • As summarized above, this invention also advantageously provides methods for producing approximately equimolar rolling circle amplification of DNA fragment mixtures. The methods are applicable to RCA of any DNA including for purposes of detection, cloning, generation of probes, GMS procedures, DNA mapping, sequencing, and genotyping. In one procedure a pause site is created by the introduction of one or more abasic sites in the template. DNA polymerases are slowed but not completely blocked by such a site. They will tend to insert a nucleotide opposite the abasic site (Randell, cited above). The pause site can be introduced into the template by standard procedures for ligating a fragment containing the pause site into a double-stranded DNA. [0027]
  • Another approach is to circularize a single-strand DNA target fragment with a splint that contains the pause site in a double-stranded internal segment and that has single-stranded ends complementary to the ends of the target fragment. Ligation of this construct results in the insertion of the abasic sequence into the target fragment. Another method is to insert a sequence containing one or more uracils as bases and then creating abasic sites by treatment with uracil glycosylase (UDG, Kornberg and Baker, cited above). The method is also applicable for other types of pause sites such as hairpin structures or protein binding sites on the DNA. [0028]
  • As a general method for amplifying any DNA fragment, an adapter is described that allows for circularization of the fragment and subsequent RCA The adapter has appropriate overhangs on its ends to allow ligation to both ends of the DNA fragment (FIG. 1G) such that annealing of the ends results in a circularized adapter-fragment construct (FIG. 1H) and ligation seals the nicks (FIG. 11). The adapter also provides for the ability to prime RCA. A single-stranded gap (FIG. 1G), or a nick, located in an internal region of the adapter, provides a 3′-OH (FIG. 1G) that can serve as a primer for DNA polymerase (FIG. 1J). The presence of a non-complementary 5′-tail (FIG. 1J) facilitates the initiation of strand displacement synthesis in which a DNA polymerase invades the duplex region of the DNA template (FIG. 1K). Embodiments of this invention employ DNA pol III to improve the rate and processivity of the RCA. [0029]
  • A method is also given for the use of DNA polymerase III for RCA using the padlock method (Nilsson, M., et al., cited above). When the padlock DNA is annealed to the target fragment (FIG. 1L) a single stranded gap is created. Extension of the 3′-OH of the padlock DNA followed by ligation results in the circularization of the padlock which is linked to the target DNA (FIG. 1M). In some cases, it is desirable to have a large gap length in order to amplify a large region of the target DNA. An advantage of this invention is that use DNA polymerase III in the extension step allows for a larger single-stranded gap length because of its superior rate and processivity. Particularly for gaps of several hundred to greater then a megabase, pot III provides greater rates and yields. Another advantage of pol III is that it has very slow rates of initiating strand displacement at a nick compared to other DNA polymerases (O'Donnell, M., and Kornberg, A., [0030] J. Biol. Chem., 1985, 260:12884). Therefore, pol III will tend not to displace the 5′-end of the padlock DNA prior to ligation.
  • Following circularization, an RCA primer is annealed to the padlock DNA (FIG. 1N) for the priming of DNA synthesis. Pol III is also employed for this reaction because of advantages in RCA mentioned above. The RCA primer can have a non-complementary 5′-tail that facilitates the initiation of strand displacement at a nick (FIG. 1N). Once RCA is initiated, DNA pot III provides superior rates and processivity for strand displacement synthesis. [0031]
  • A general method is also given for polymorphism analysis of repeat sequences such as di- and tri-nucleotide repeats and other microsatellite sequences which are frequently used because of their high level of polymorphism. By amplifying the sequences in an RCA, artifacts associated with PCR are reduced. In PCR reactions, slippage of the DNA polymerase results in accumulating errors, usually by addition or deletion of the repeated sequence. Because RCA is a linear amplification in which the same DNA template is repeatedly copied, replication errors do not accumulate exponentially as they do in a PCR in which the product DNA of one cycle can serve as the template in a subsequent cycle. The use of DNA polymerase III in the reaction reduces the errors because of the highly processive synthesis and fidelity of the enzyme (Kornberg and Baker, cited above). [0032]
  • In another embodiment of the invention, methods are given for converting DNA fragments into a form that can be utilized as RCA templates by ligation of hairpin forming adapters to the ends of the fragments (FIG. 2). The adapters contain self-complementary sequences at their 3′ and 5′ ends such that they form stem and loop structures. Furthermore, the stem portion of the hairpin structures create blunt or overhanging ends that allow the adapter to be ligated to the end of any DNA fragments having the appropriate end. By ligating such adapters to both ends of the DNA fragments, the fragments are converted to a circular form which can be utilized as the template for an RCA reaction. Also, the loop portion of the adapters provide a single-stranded region to which the RCA primer can be annealed. [0033]
  • The constructs formed can be amplified in an RCA using a primer complementary to the adapters. The method allows for a whole genome amplification in which a subset of DNA segments derived from the original DNA sample are amplified. [0034]
  • Another invention uses two or more DNA polymerases in an RCA reaction. At least one of the DNA polymerases possesses a 3′→5′ exonuclease proofreading activity capable of correcting base mispairs. The removal of misincorporated bases allows for greater primer extension. [0035]
  • EXAMPLES Example 1
  • Effect of T7 Native DNA Polymerase (with 3′→5′ exonuclease) and of Deoxynucleotide Concentration on M13 Rolling Circle Amplification [0036]
  • This example demonstrates that the presence of a small amount of the native T7 DNA polymerase, which contains a 3′→5′ exonuclease, stimulates the maximum rate of synthesis by sequenase (FIG. 3). Sequenase is present at a saturating concentration (26 units) and so it is concluded that the T7 polymerase is not stimulating the reaction by simply increasing the total DNA polymerase units in the reaction. Rather, it is concluded that T7 polymerase is stimulating the reaction by removing mismatched nucleotides which block primer extension. [0037]
  • RCA reactions were performed at 37° C. and aliquots were removed at 1, 2, and 3 hours, as indicated, in a reaction volume of 50 microliters containing 20 mM Tris-acetate, 10 mM magnesium acetate, and 50 mM potassium acetate, pH 7.9@25° C., 0.2 mM or 1.0 mM each deoxynucleoside triphosphate, as indicated, 2 [0038] uCi 5′-[-32P] dCTP (Amersham Pharmacia Biotech), 30 ng of M13 singly-primed single-stranded M13 DNA (see below), 4.2 micrograms of E.coli single-strand DNA binding protein (Studwell & O'Donnell, J. Biol. Chem. 265:1175-1178, 1990), 26 units of Sequenase 2.0 (United States Biochemical), and 0.5 unit of T7 native DNA polymerase, cloned (United States Biochemical), as indicated. Aliquots (4 ul) were spotted onto DE81 filter paper and deoxynucleotide incorporation was determined.
  • Singly-primed Single-stranded M13 Viral (+) Strand DNA. [0039]
  • Annealing reactions (100 microliters) contained 20 mM Tris-HCl pH 7.5, 40 mM NaCl, 500 mM primer F4 and 6.5 microliters M13 viral (+) strand DNA (27.6 nM M13 single-strand DNA circles). Reactions were heated to 95° C. for 1 min and cooled slowly over 30 min. The primer:circle ratio=18. Primer F4 (5′-TCT GTT TAT AGG GCC TCT TCG CTA TTA CGC CAG C-3′) consisted of 24 nucleotides at the 3′ end complementary to M13mp19 (+) strand, and 10 nucleotides non-complementary at the 5′ end. The 3′ end is at M13 map position 6377. [0040]
  • Example 2
  • Effect of T7 Native DNA Polymerase (with 3′→5′ exonuclease) Concentration on M13 Rolling Circle Amplification [0041]
  • This example shows the dependence on T7 DNA polymerase concentration of the stimulation of RCA reactions using sequenase (FIG. 4). RCA reactions were performed for 3 hr as described in Example 1 except that T7 native polymerase was added as indicated. Aliquots (4ul) were spotted onto DE81 filter paper and deoxynucleotide incorporation was determined. [0042]
  • Example 3
  • Rolling Circle Amplification (RCA) Assay using reconstituted DNA polymerase III holoenzyme (Kelman and O'Donnell, [0043] Annu. Rev. Biochem. 64: 171-200, 1995), and accessory replication proteins including DnaB helicase (Arai et al., J. Biol. Chem. 256: 5247-5252, 1981), DnaG primase (Rowen and Kornberg, J. Biol. Chem. 253: 758-764, 1978) and SSB (Studwell and O'Donnell, J. Biol. Chem. 265: 1175-1178, 1990).
  • This example demonstrates the product formed using DNA polymerase III holoenzyme and primed M13 single-stranded DNA as the template. The product strands are larger than 12 kb (see the arrow in FIG. 5, for (−) EcoR I). To prove that the product DNA consisted of tandem repeats of the M13 sequence, as predicted for an RCA reaction, the reaction products were digested with [0044] EcoR 1 which converted the product DNA to unit lengths of 7250 kb (FIG. 3, (+) EcoR1).
  • RCA assays were in 50 μl of Reaction buffer (HEPES-NaOH (pH7.4), 12 mM MgCl[0045] 2, 5 mM DTT, 100 μg BSA/ml, 5 mM ATP, 20% Glycerol (v/v)) containing 325 ng (138 fmol) M13mp19 (+) ssDNA as template, 2.5 pmol of F4 primer (5′-TCT GTT TAT AGG GCC TCT TCG CTA TTA CGC CAG C-3′, the underlined sequence annealed to position 6377-6400 on M13mp19 (+) strand), 1.25 pmol (as dimer) of β clamp, 1 pmol of Pol III*, 5.5 pmol (as hexamer) of DnaB (helicase), 15.4 pmol of DnaG (primase), 54.2 pmol (as tetramer) of SSB, 50 nM each ATP, UTP, GTP, and CTP, 400 μM each dATP, dTTP, dGTP, and α32P-CTP (3000-6000 cpm/pmol). All additions were made at 0° C., and then reactions were shifted to 37° C. and quenched with EDTA at a final concentration of 67 mM after 1 hour incubation at 37° C. An aliquot of amplification products was quantitated by spotting onto DE81 filters as described (Rowen and Kornberg, 1978). After washing and drying, the filters were counted in a liquid scintillation counter (Packard). Another aliquot (2 μl) was digested with EcoR I or incubated with only EcoR I buffer at 37° C. for 1 hour. The digestion mix was treated with Protease K for 30 minute and then analyzed on a 0.7% alkaline gel followed by exposing to storage Phosphor screen and quantitated using ImageQuant software (Molecular Dynamics).
  • The above description is for the purpose of teaching the person of ordinary skill in the art how to practice the present invention, and it is not intended to detail all those obvious modifications and variations of it which will become apparent to the skilled worker upon reading the description. There are numerous variations of steps in the overall procedures, and for preparing the probes. In some embodiments, for example, the primer or DNA fragment is tagged with biotin or the like and captured with strepavidin or avidin or the like using standard procedures (Geschwind, D. H., et al., [0046] Genetic Analysis, 1996, 13:105-111). Selective cleavage of DNA using RecA-assisted restriction endonuclease (RARE) may be employed (Ferrin, L. J., and Camerini-Otero, R. D., Science, 1991, 254:1494-1497). It is intended, however, that all such obvious modifications and variations be included within the scope of the present invention, which is defined by the following claims. The claims are intended to cover the claimed components and steps in any sequence which is effective to meet the objectives there intended, unless the context specifically indicates the contrary.
  • The papers, books and patents cited herein are expressly incorporated in their entireties by reference. [0047]
  • 1 1 1 34 DNA Artificial Sequence 24 nucleotides at the 3′ end complementary to M13mp19(+) (at map position 6377) and 10 nucleotides non-complementary at the 5′ end 1 tctgtttata gggcctcttc gctattacgc cagc 34

Claims (59)

1. A method for isolating mismatched DNA containing fragments nicked by MutSLH from two DNA samples comprising:
(a) digesting a first DNA sample with a restriction enzyme to obtain DNA fragments;
(b) ligating Y-shaped adapters to the fragments to obtain fragment-plus-adapter constructs;
(c) repeating steps (a) through (b) with a second sample;
(d) methylating the products formed from step (c) of the first sample but not the second;
(e) mixing the methylated and unmethylated products obtained from the samples, denaturing, and reannealing to form hemimethylated heterohybrids;
(f) treating the fragments produced in step (e) with a MutSLH preparation in order to nick DNA containing mismatches and form a 3′-OH end; and
(g) elongating the 3′-OH end with one or more DNA polymerase.
2. A method according to
claim 1
in which the DNA polymerase is DNA pol III or a subassembly of DNA pol III holoenzyme.
3. A method according to
claim 1
in which the the step of elongation employs in addition to the DNA polymerase, a polypeptide selected from the group consisting of dnaB, dnaG, dnaC, other helicases, SSB, and mixtures thereof.
4. A method according to
claim 1
further comprising the steps of
(h) annealing a splint oligonucleotide wherein the splint oligonucleotide is complementary to the sequences at the 5′- and 3-ends of DNA produced by elongation in step (g) such that annealing of the splint oligonucleotide circularizes the strand so that a nick is formed that can be ligated, wherein a 5′-end of the splint oligonucleotide is either completely complementary or complementary but for a non-complementary region serving to facilitate the initiation of strand displacing synthesis in a subsequent rolling circle amplification;
(i) annealing this oligonucleotide to the denatured single strands from step (g);
(j) ligating the product of step (i) with DNA ligase; and
(k) incubating the product of step (j) with a DNA polymerase in the presence of deoxynucleoside triphosphates to extend the 3′-end of the splint oligonucleotide in a rolling circle DNA amplification reaction.
5. A method according to
claim 4
in which the step of incubating employs a polypeptide selected from the group consisting of dnaB, dnaG, dnaC, other helicases, SSB, and mixtures thereof.
6. A method for isolating mismatched DNA containing fragments nicked by MutSLH from two DNA samples comprising:
(a) digesting a first DNA sample with a restriction enzyme to obtain DNA fragments;
(b) ligating adapters to the fragments to obtain fragment-plus-adapter constructs that have a single-stranded overhang on the 5′-ends and recessed 3′-ends, wherein the adapters are blocked with a dideoxynucleotide or other modification that prevents their elongation by a DNA polymerase;
(c) repeating steps (a) through (b) with a second DNA sample;
(d) methylating the products formed from step (c) of the first sample but not the second sample;
(e) mixing methylated and unmethylated products of step (e) denaturing, and reannealing to form hemnimethylated heterohybrids;
(f) blocking pre-existing nicks on the fragments obtained in step (f) with dideoxy nucleoside triphosphates or their analogues;
(g) treating the fragments produced in step (f) with a MutSLH preparation to form 3′ OH ends; and
(h) elongating the 3′-OH ends with a DNA polymerase having strand displacement or nick translation capacity.
7. A method according to
claims 1
to
6
wherein the pre-existing nicks in step (h) are blocked with dideoxynucleoside triphosphates.
8. A method according to
claims 1
to
6
wherein the polymerase having strand displacement capacity is φ29 DNA polymerase.
9. A method for amplifying DNA using rolling circle amplification in a manner that results in approximately equimolar amplification of the DNA, comprising the steps of amplifying a circle DNA molecule which comprises a stem-and-loop, or a circle DNA molecule containing a universal base, an abasic residue, or other residue that alters the rate of circle replication, whereby elongation of the circle by a replicating polymerase carrying out the amplification is inhibited.
10. A method according to
claim 9
which employs a DNA molecule which was nicked with MutSLH.
11. A method for using rolling circle amplification to obtain approximately equimolar amplification of DNA fragment mixtures by introducing at least one pause site in a DNA circle by a step selected from the group consisting of:
(a) placing within the circle a stretch of one more abasic sites;
(b) placing within the circle a region of high secondary structure; and
(c) placing within the circle a ligand binding site,
and then carrying out rolling circle amplification under conditions such that the pause site slows the DNA polymerase replicating the circle and tends to equalize the number of times the polymerase copies circles of different length.
12. A method according to
claim 11
in which an abasic site is introduced by inserting a uracil into the DNA and treating with UDG.
13. A method for using rolling circle amplification to obtain approximately equimolar amplification of DNA fragment mixtures by introducing at least one pause site into a DNA circle by a step selected from the group consisting of:
(a) circularizing double-stranded DNA fragments around an adapter such that one strand of the adapter has an internal pause and the other strand is blocked from ligation at one or both ends; or
(b) using a splint that has an internal double stranded segment containing a pause site on one DNA strand, and which has single stranded extensions at both ends complementary to the ends of the single-stranded fragment to be amplified.
14. A method according to
claim 11
wherein the ligand binding site is for a tight binding protein.
15. A method according to
claim 14
wherein the tight binding protein is a high afnity lac repressor.
16. A method according to
claim 11
wherein the pause site is thermally reversible.
17. A method according to
claim 16
wherein the circle is replicated with a thermo-stable polymerase.
18. A method according to
claim 17
wherein the thermo-stable polymerase is Pfu1 or DNA polymerase III from a thermo-stable bacteria.
19. A method according to
claim 17
wherein the thermo-stable polymerase is Pfu1 or DNA polymerase III from a thermo-stable bacteria.
20. A method according to
claim 11
wherein the circle contains a stem-and-loop structure as a region of high secondary structure.
21. A method according to
claim 20
wherein the stem-and-loop structure is inserted into a single position in all the circles.
22. A method according to
claim 21
wherein the stem-and-loop structure is inserted into the circle by ligating circles around an adapter.
23. A method according to
claims 16
to
22
wherein the stem-and-loop structure has a melting point range that inhibits elongation of the polymerase catalyzing circle replication in a first temperature range but not in a second temperature range, provided there is some polymerase activity in the second temperature range.
24. A method according to claims 9 or 11 to 22 wherein the region of high secondary structure in the circle anneals to a modified oligonucleotide that binds to the the secondary structure in the circle at a first temperature range so as to block elongation during circle replication, but not in a second temperature range, such that the modified oligonucleotide melts off the circle with a shift from the first temperature range to the second temperature range, such that elongation by a polymerase catalyzing circle replication is inhibited.
25. A method according to
claims 11
to
22
wherein the circle contains a universal base, an abasic residue, or other residue that alters the rate of circle replication such that elongation of the circle by a replicating polymerase is inhibited.
26. A method in which fragments of DNA may be circularized and amplified comprising:
(a) cutting DNA with a restriction enzyme that produces a single fragment containing all the markers of the region having phase to be determined, or using the RARE method or its variants to produce such a fragment;
(b) ligating the cut DNA around an adapter; and
(c) amplifying the fragment using rolling circle amplification to obtain a single-stranded DNA from the desired fragment.
27. A method according to
claim 26
wherein the primer used in step (c) is an oligonucleotide that has, at its 3′-end, a base complementary to the sequence at only one of the two variants present at a heterozygous marker site.
28. A method according to
claim 26
wherein only one strand of the single fragment is circularized by employing an adapter in step (b) that lacks a phosphate at one end, or has a 3′-dideoxy terminus, or some other terminal group that blocks extension by a DNA polymerase, on one strand, or an internal gap.
29. A method according to
claim 27
wherein amplification is carried out using a first primer complementary to a homozygous sequence in the region of interest and a second primer which is complementary to the strand that was amplified and which has a 3′ end complementary to only one allele of a heterozygous marker in the region.
30. A method according to any of
claims 26
to
29
in which the single-strand DNA product of a rolling circle amplification is used as a template for subsequent DNA synthesis by primer extension or hyperbranching synthesis using primers having 3′-ends complementary to only one allele of a heterozygous marker or complementary to any other sequence of the single-stranded DNA.
31. A method according to
claim 26
further comprising the steps of:
selectively recovering amplified double stranded DNA; and
analyzing the double stranded DNA to determine which form of a heterozygous marker is present.
32. A method according to
claim 26
wherein the adapter contains at least one pause site.
33. A method according to
claim 26
wherein the DNA is genomic DNA.
34. A method according to
claim 26
wherein the fragment is from about 5 kb to 2 Mb.
35. A method according to
claim 33
wherein the fragment contains a stem-and-loop structure.
36. A method according to
claim 26
in which the fragment is circularized around an adapter with an internal single stranded gap which provides a 3′-terminal hydroxyl, and rolling circle DNA amplification is primed at the 3′-terminal hydroxyl.
37. A method according to
claim 26
wherein at least one locus is selectively isolated by protecting specific occurrences of a restriction endonuclease site by annealing a complementary oligonucleotide, blocking any other restriction endonuclease sites present using enzymatic methylation, removing the complementary oligonucleotides, releasing the DNA fragment between the specific occurrences of the restriction endonuclease sites by cleaving with the restriction endonuclease, circularizing the released DNA fragment, and amplifying the circularized DNA fragment using a DNA polymerase.
38. A method according to
claim 34
in which the fragment is circularized around an adapter with an internal single stranded gap, and annealing an RCA primer to the single stranded gap.
39. A method according to any of
claims 26
to
38
wherein DNA from two allelic loci in a sample are separated by amplifying both allelic loci by a rolling circle amplification generating single-stranded DNA, adding allele-specific primers, wherein each primer is complementary to one of the single-stranded DNA strands with the nucleotide present at the 3′-end of the primer being complementary to only one of the two allelic loci, and extending the primers with DNA polymerase to generate double-stranded DNA.
40. A method according to
claim 39
wherein the primer is biotinylated.
41. A method according to
claim 38
wherein the double-stranded DNA so produced is analyzed using rolling circle enrichment or depletion of one of the strands.
42. A method according to
claim 39
wherein the double-stranded DNA so produced is digested with a restriction enzyme that cleaves only double-stranded DNA.
43. A method according to
claim 39
wherein the DNA is methylated.
44. A method according to
claims 26
to
29
,
31
to 38, or 40 to 43 in which the rolling circle amplification employs a polypeptide selected from the group consisting of dnaB, dnaG, dnaC, other helicases, SSB, and mixtures thereof.
45. A method for amplifying segments of a DNA target by RCA comprising:
(a) annealing a padlock DNA that creates a gap comprising the sequence to be amplified;
(b) extending the 3′-OH of the padlock DNA with a DNA polymerase which generates a nick;
(c) ligating the nick to form a circle DNA;
(d) annealing an RCA primer to the circle DNA generated in step c); and
(e) carrying out RCA with DNA polymerase III.
46. A method according to
claim 45
in which a polypeptide selected from the group consisting of dnaB, dnaG, dnaC, other helicases, SSB, and mixtures thereof, is used in step (b) or step (e) with the DNA polymerase.
47. A method according to
claim 45
in which the RCA primer has a non-complementary tail at the 5′-end to facilitate initiation of strand displacement.
48. A method for polymorphism analysis comprising:
employing DNA polymerase III in RCA for the amplification nucleotide repeats.
49. A method according to
claims 1
to
6
,
9
, 11 to 22, 26 to 29, 31 to 38, 40 to 43, or 45 to 48 which employs DNA polymerase III in RCA.
50. A method in which large fragments of DNA may be circularized and amplified comprising:
(a) providing a DNA-adapter construct which has a DNA fragment ligated around an adapter that has an internal gap and a 5′ region of non-complementarity; and
(b) amplifying the DNA-adapter construct using DNA pol III in a rolling circle amplification.
51. A method according to
claim 50
in which rolling circle amplification is performed in the presence of a polypeptide selected from the group consisting of dnaB, dnaG, dnaC, other helicases, SSB, and mixtures thereof.
52. A method according to
claim 50
wherein a primer is used in step (b) which is an oligonucleotide that has, at its 3′-end, a base complementary to only one allelic variant present at a heterozygous marker site.
53. A method according to
claim 50
wherein only one strand of the DNA fragment is circularized by employing an adapter in step (a) that lacks a phosphate at one end, or has a 3′-dideoxy terminus, or some other terminal group that blocks extension by a DNA polymerase, on one strand, or an internal gap, and wherein the step of amplifying is carried out using a first primer complementary to a homozygous sequence in the region of interest and a second primer complementary to the strand that was amplified, wherein the second primer is complementary at its 3′ end to only one allele of a heterozygous marker in the region.
54. A method according to
claims 50
to
53
in which a single-strand DNA product of the rolling circle amplification is used as a template for subsequent DNA synthesis by primer extension or hyperbranching synthesis using primers having 3′-ends complementary to only one allele of a heterozygous marker or having 3′-ends complementary to any other sequence of the single-stranded DNA.
55. A method for ligating adapters onto ends of DNA fragments for use in rolling circle amplification of the DNA comprising:
ligating restriction endonuclease fragments with an oligonucleotide adapter that forms a hairpin structure with itself such that 3′ and 5′ ends of the adapter are annealed together and form a proper overhang or blunt end for ligation to the restriction endonuclease fragments, whereby a circular construct is formed;
annealing an oligonucleotide primer to the single-stranded loop portion of the adapters;
extending the oligonucleotide primer with a DNA polymerase in a rolling circle amplification reaction.
56. A method according to
claim 55
in which the restriction endonuclease fragments are generated with more than one restriction endonuclease so that different overhangs are formed on either end of a fragment and ligating different adapters which have cognate overhanging ends onto the fragments.
57. A method according to
claim 55
or
56
in which the restriction endonuclease fragments are derived from genomic DNA, and the ligated constructs are used for whole genome amplification by RCA.
58. A method according to
claim 55
or
56
in which a mixture of restriction endonuclease fragments or cDNA fragments is used for the purpose of amplifying the DNA in a rolling circle amplification reaction.
59. A method for carrying out a rolling circle amplification reaction wherein at least two different DNA polymerases are employed, one or more of which contains a 3′→5′ exonuclease activity capable of correcting nucleotide misincorporations.
US09/820,356 1998-09-18 2001-03-29 Methods for selectively isolating DNA using rolling circle amplification Abandoned US20010039039A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/820,356 US20010039039A1 (en) 1998-09-18 2001-03-29 Methods for selectively isolating DNA using rolling circle amplification

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10099698P 1998-09-18 1998-09-18
US10093598P 1998-09-18 1998-09-18
US09/398,216 US6235502B1 (en) 1998-09-18 1999-09-17 Methods for selectively isolating DNA using rolling circle amplification
US09/820,356 US20010039039A1 (en) 1998-09-18 2001-03-29 Methods for selectively isolating DNA using rolling circle amplification

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/398,216 Division US6235502B1 (en) 1998-09-18 1999-09-17 Methods for selectively isolating DNA using rolling circle amplification

Publications (1)

Publication Number Publication Date
US20010039039A1 true US20010039039A1 (en) 2001-11-08

Family

ID=27379102

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/398,216 Expired - Lifetime US6235502B1 (en) 1998-09-18 1999-09-17 Methods for selectively isolating DNA using rolling circle amplification
US09/818,927 Expired - Lifetime US6576448B2 (en) 1998-09-18 2001-03-28 Methods for selectively isolating DNA using rolling circle amplification
US09/820,356 Abandoned US20010039039A1 (en) 1998-09-18 2001-03-29 Methods for selectively isolating DNA using rolling circle amplification

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/398,216 Expired - Lifetime US6235502B1 (en) 1998-09-18 1999-09-17 Methods for selectively isolating DNA using rolling circle amplification
US09/818,927 Expired - Lifetime US6576448B2 (en) 1998-09-18 2001-03-28 Methods for selectively isolating DNA using rolling circle amplification

Country Status (1)

Country Link
US (3) US6235502B1 (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150919A1 (en) * 2000-10-27 2002-10-17 Sherman Weismann Methods for identifying genes associated with diseases or specific phenotypes
WO2003044229A1 (en) * 2001-11-20 2003-05-30 Mats Gullberg Nucleic acid enrichment
US20030104431A1 (en) * 2001-07-15 2003-06-05 Keck Graduate Institute Nucleic acid amplification using nicking agents
US20030152952A1 (en) * 2001-07-15 2003-08-14 Keck Graduate Institute Methylation analysis using nicking agents
US20040191816A1 (en) * 1992-08-04 2004-09-30 Replicon, Inc. In vitro amplification of nucleic acid molecules via circular replicons
US20080305535A1 (en) * 1992-08-04 2008-12-11 Replicon, Inc. In vitro amplification of nucleic acid molecules via circular replicons
EP2048248A1 (en) * 2007-10-11 2009-04-15 Samsung Electronics Co., Ltd. Method of amplifying a target nucleic acid by rolling circle amplification
US20100009411A1 (en) * 2008-07-08 2010-01-14 General Electric Company Method and Kits for Repairing Nucleic Acid Sequences
WO2011120046A2 (en) * 2010-03-26 2011-09-29 Swift Biosciences, Inc. Methods and compositions for isolating polynucleotides
US20130280713A1 (en) * 2012-04-20 2013-10-24 Samsung Electronics Co., Ltd. Polynucleotide and use thereof
US20130344485A1 (en) * 2010-12-07 2013-12-26 Gnubio, Inc. Nucleic acid target detection using a detector, a probe and an inhibitor
US20140141418A1 (en) * 2012-11-19 2014-05-22 Samsung Electronics Co., Ltd. Polynucleotide and use thereof
EP2740806A3 (en) * 2008-11-07 2014-08-20 Industrial Technology Research Institute Methods for accurate sequence data and modified base position determination
US20150038691A1 (en) * 2013-07-31 2015-02-05 International Business Machines Corporation Polynucleotide configuration for reliable electrical and optical sensing
EP2970961A4 (en) * 2013-03-15 2016-12-21 Theranos Inc Nucleic acid amplification
RU2616279C1 (en) * 2015-12-28 2017-04-13 Федеральное государственное бюджетное учреждение науки Институт биохимии и генетики Уфимского научного центра Российской академии наук (ИБГ УНЦ РАН) Method for production of marker ladders for gel electrophoretic determination of nucleic acid fragment sizes
CN110643680A (en) * 2016-05-27 2020-01-03 深圳市海普洛斯生物科技有限公司 Linker suitable for ultramicro DNA sequencing and application thereof
US20200024655A1 (en) * 2011-07-25 2020-01-23 Oxford Nanopore Technologies Ltd. Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
US10745745B2 (en) 2013-03-15 2020-08-18 Labrador Diagnostics Llc Nucleic acid amplification
US11155860B2 (en) 2012-07-19 2021-10-26 Oxford Nanopore Technologies Ltd. SSB method
US11186857B2 (en) 2013-08-16 2021-11-30 Oxford Nanopore Technologies Plc Polynucleotide modification methods
US11254960B2 (en) 2013-03-15 2022-02-22 Labrador Diagnostics Llc Nucleic acid amplification
US11352664B2 (en) 2009-01-30 2022-06-07 Oxford Nanopore Technologies Plc Adaptors for nucleic acid constructs in transmembrane sequencing
US11542551B2 (en) 2014-02-21 2023-01-03 Oxford Nanopore Technologies Plc Sample preparation method
US11560589B2 (en) 2013-03-08 2023-01-24 Oxford Nanopore Technologies Plc Enzyme stalling method
US11649480B2 (en) 2016-05-25 2023-05-16 Oxford Nanopore Technologies Plc Method for modifying a template double stranded polynucleotide
US11725205B2 (en) 2018-05-14 2023-08-15 Oxford Nanopore Technologies Plc Methods and polynucleotides for amplifying a target polynucleotide

Families Citing this family (168)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854033A (en) * 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US7195871B2 (en) * 1996-01-24 2007-03-27 Third Wave Technologies, Inc Methods and compositions for detecting target sequences
US7256020B2 (en) * 1996-11-29 2007-08-14 Third Wave Technologies, Inc. Methods and compositions for detecting target sequences
EP1238105A2 (en) * 1999-12-02 2002-09-11 Molecular Staging Inc. Generation of single-strand circular dna from linear self-annealing segments
US6323009B1 (en) * 2000-06-28 2001-11-27 Molecular Staging, Inc. Multiply-primed amplification of nucleic acid sequences
WO2002090572A2 (en) * 2001-05-09 2002-11-14 Third Wave Technologies, Inc. Nucleic acid detection in pooled samples
US20040078837A1 (en) * 2001-08-02 2004-04-22 Shannon Mark E. Four human zinc-finger-containing proteins: MDZ3, MDZ4, MDZ7 and MDZ12
GB2378245A (en) 2001-08-03 2003-02-05 Mats Nilsson Nucleic acid amplification method
MXPA04003926A (en) * 2001-10-24 2004-06-18 Singulex Inc Methods for detecting genetic haplotypes by interaction with probes.
WO2003044645A1 (en) * 2001-11-16 2003-05-30 Martin Chalk Communications device and supporting network
US7553619B2 (en) * 2002-02-08 2009-06-30 Qiagen Gmbh Detection method using dissociated rolling circle amplification
CN1182256C (en) * 2002-08-09 2004-12-29 周国华 Gene expression amount comparing analysis method
US7662594B2 (en) * 2002-09-20 2010-02-16 New England Biolabs, Inc. Helicase-dependent amplification of RNA
ATE414792T1 (en) * 2002-09-20 2008-12-15 New England Biolabs Inc HELICASE-DEPENDENT AMPLIFICATION OF NUCLEIC ACIDS
US20050118602A1 (en) * 2002-10-10 2005-06-02 Yin-Xiong Li Gene profiling of single or multiple cells
US20060147938A1 (en) * 2002-11-14 2006-07-06 Third Wave Technologies, Inc. CFTR allele detection assays
US20040096871A1 (en) * 2002-11-14 2004-05-20 Molly Accola CFTR allele detection assays
US7312033B2 (en) * 2002-11-14 2007-12-25 Third Wave Technologies, Inc. CFTR allele detection assays
ATE411400T1 (en) * 2002-11-21 2008-10-15 Epict Technologies METHOD FOR USING RIBOPRIMERS FOR STRAND DISPLACEMENT REPLICATION OF TARGET SEQUENCES
US7851150B2 (en) 2002-12-18 2010-12-14 Third Wave Technologies, Inc. Detection of small nucleic acids
US8206904B2 (en) 2002-12-18 2012-06-26 Third Wave Technologies, Inc. Detection of nucleic acids
ATE525469T1 (en) 2002-12-18 2011-10-15 Third Wave Tech Inc DETECTION OF SMALL NUCLEIC ACIDS
US20040121338A1 (en) * 2002-12-19 2004-06-24 Alsmadi Osama A. Real-time detection of rolling circle amplification products
US9487823B2 (en) 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification
WO2004065582A2 (en) * 2003-01-15 2004-08-05 Dana-Farber Cancer Institute, Inc. Amplification of dna in a hairpin structure, and applications
GB2398383B (en) * 2003-02-12 2005-03-09 Global Genomics Ab Method and means for nucleic acid sequencing
US8206913B1 (en) 2003-03-07 2012-06-26 Rubicon Genomics, Inc. Amplification and analysis of whole genome and whole transcriptome libraries generated by a DNA polymerization process
US8043834B2 (en) * 2003-03-31 2011-10-25 Qiagen Gmbh Universal reagents for rolling circle amplification and methods of use
US7300755B1 (en) * 2003-05-12 2007-11-27 Fred Hutchinson Cancer Research Center Methods for haplotyping genomic DNA
US20040248103A1 (en) * 2003-06-04 2004-12-09 Feaver William John Proximity-mediated rolling circle amplification
DE10332620A1 (en) * 2003-07-18 2005-02-10 Eppendorf Ag Method for detecting biomolecules, e.g. proteins, sugars or nucleic acid, comprises that it is based on reconstitution of a nucleic acid replication system and generation of labeled replicons
US20050074804A1 (en) * 2003-09-26 2005-04-07 Youxiang Wang Amplification of polynucleotide sequences by rolling circle amplification
WO2005047547A1 (en) * 2003-11-04 2005-05-26 Applera Corporation Concatameric ligation products: compositions, methods and kits for same
EP2290106B1 (en) * 2004-03-08 2018-01-03 Rubicon Genomics, Inc. Method for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation
FR2868071B1 (en) * 2004-03-26 2006-06-09 Biomerieux Sa MARKING REAGENTS, METHODS FOR SYNTHESIZING SUCH REAGENTS AND METHODS FOR DETECTING BIOLOGICAL MOLECULES
ES2292270B1 (en) 2004-04-14 2009-02-16 Oryzon Genomics, S.A. PROCEDURE FOR SELECTLY DETECTING NUCLEIC ACIDS WITH ATIPIC STRUCTURES CONVERTIBLE IN MUESCAS.
FR2873388B1 (en) * 2004-07-23 2012-04-06 Biomerieux Sa PROCESS FOR MARKING AND PURIFYING NUCLEIC ACIDS OF INTEREST PRESENT IN A BIOLOGICAL SAMPLE TO BE PROCESSED IN A SINGLE REACTION RECIPIENT
US20060194214A1 (en) * 2005-02-28 2006-08-31 George Church Methods for assembly of high fidelity synthetic polynucleotides
US20070259356A1 (en) * 2004-11-04 2007-11-08 Applera Corporation Concatameric Ligation Products: Compositions, Methods and Kits for Same
KR20070093992A (en) * 2004-12-11 2007-09-19 사이토제닉, 인크. Cell free biosynthesis of high-quality nucleic acid and uses thereof
US20060252032A1 (en) * 2005-01-28 2006-11-09 Third Wave Technologies, Inc. Detection of human herpesviruses
US8309303B2 (en) 2005-04-01 2012-11-13 Qiagen Gmbh Reverse transcription and amplification of RNA with simultaneous degradation of DNA
SG162795A1 (en) 2005-06-15 2010-07-29 Callida Genomics Inc Single molecule arrays for genetic and chemical analysis
JP4860199B2 (en) 2005-07-29 2012-01-25 アイシン精機株式会社 Modified single-stranded DNA-binding protein derived from highly thermophilic bacteria, and method for isothermal amplification of nucleic acid using the protein
DK1924704T3 (en) 2005-08-02 2011-09-05 Rubicon Genomics Inc Compositions and Methods for Processing and Multiplying DNA, including Using Multiple Enzymes in a Single Reaction
US20080014124A1 (en) * 2005-08-04 2008-01-17 Third Wave Technologies, Inc. Sample processing devices, systems and methods
EP1762627A1 (en) 2005-09-09 2007-03-14 Qiagen GmbH Method for the activation of a nucleic acid for performing a polymerase reaction
US7960104B2 (en) 2005-10-07 2011-06-14 Callida Genomics, Inc. Self-assembled single molecule arrays and uses thereof
US8831887B2 (en) * 2005-10-12 2014-09-09 The Research Foundation For The State University Of New York Absolute PCR quantification
US7482127B2 (en) * 2005-11-03 2009-01-27 Third Wave Technologies, Inc. Nucleic acid detection assays employing blocker oligonucleotides
WO2007059348A2 (en) * 2005-11-17 2007-05-24 Third Wave Technologies, Inc. Compositions and methods for detecting an hcv-1 subtype
FR2902430B1 (en) * 2005-11-25 2012-11-02 Biomerieux Sa OLIGONUCLEOTIDES, USE, DETECTION METHOD AND KIT FOR DIAGNOSING THE PRESENCE OF INFLUENZA VIRUS H5 AND N1 GENES
US20070168197A1 (en) * 2006-01-18 2007-07-19 Nokia Corporation Audio coding
CN101432439B (en) * 2006-02-24 2013-07-24 考利达基因组股份有限公司 High throughput genome sequencing on DNA arrays
SG10201405158QA (en) * 2006-02-24 2014-10-30 Callida Genomics Inc High throughput genome sequencing on dna arrays
JP5260503B2 (en) 2006-06-01 2013-08-14 サード ウェーブ テクノロジーズ,インコーポレーテッド Nucleic acid detection
US20080131875A1 (en) * 2006-06-07 2008-06-05 Third Wave Technologies, Inc. Multiplex assays
US7759062B2 (en) * 2006-06-09 2010-07-20 Third Wave Technologies, Inc. T-structure invasive cleavage assays, consistent nucleic acid dispensing, and low level target nucleic acid detection
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
WO2008045251A2 (en) 2006-10-04 2008-04-17 Third Wave Technologies, Inc. Snap-back primers and detectable hairpin structures
US7910354B2 (en) 2006-10-27 2011-03-22 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
US20080221832A1 (en) * 2006-11-09 2008-09-11 Complete Genomics, Inc. Methods for computing positional base probabilities using experminentals base value distributions
US20090111705A1 (en) * 2006-11-09 2009-04-30 Complete Genomics, Inc. Selection of dna adaptor orientation by hybrid capture
US20080242560A1 (en) * 2006-11-21 2008-10-02 Gunderson Kevin L Methods for generating amplified nucleic acid arrays
US20100291636A1 (en) * 2007-06-11 2010-11-18 Olink Genomics Ab Method for introducing common and/or individual sequence elements in a target nucleic acid molecule
FR2917090B1 (en) * 2007-06-11 2012-06-15 Biomerieux Sa MARKING REAGENTS HAVING DIAZO AND NITRO FUNCTIONS, METHODS FOR SYNTHESIZING SUCH REAGENTS AND METHODS FOR DETECTING BIOLOGICAL MOLECULES
GB0713183D0 (en) * 2007-07-06 2007-08-15 King S College London Method
WO2009033156A2 (en) * 2007-09-07 2009-03-12 Third Wave Technologies, Inc. Methods and applications for target quantification
FR2921064A1 (en) * 2007-09-14 2009-03-20 Biomerieux Sa OLIGONUCLEOTIDES, USE, DETECTION METHOD AND KIT FOR DIAGNOSING THE PRESENCE OF THE CHIKUNGUNYA VIRUS E1 GENE
US8518640B2 (en) * 2007-10-29 2013-08-27 Complete Genomics, Inc. Nucleic acid sequencing and process
US7897344B2 (en) * 2007-11-06 2011-03-01 Complete Genomics, Inc. Methods and oligonucleotide designs for insertion of multiple adaptors into library constructs
US8415099B2 (en) 2007-11-05 2013-04-09 Complete Genomics, Inc. Efficient base determination in sequencing reactions
WO2009061840A1 (en) * 2007-11-05 2009-05-14 Complete Genomics, Inc. Methods and oligonucleotide designs for insertion of multiple adaptors employing selective methylation
WO2009073629A2 (en) 2007-11-29 2009-06-11 Complete Genomics, Inc. Efficient shotgun sequencing methods
US8592150B2 (en) 2007-12-05 2013-11-26 Complete Genomics, Inc. Methods and compositions for long fragment read sequencing
WO2009094583A1 (en) * 2008-01-23 2009-07-30 Complete Genomics, Inc. Methods and compositions for preventing bias in amplification and sequencing reactions
WO2009097368A2 (en) 2008-01-28 2009-08-06 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US20090215050A1 (en) * 2008-02-22 2009-08-27 Robert Delmar Jenison Systems and methods for point-of-care amplification and detection of polynucleotides
WO2009120374A2 (en) 2008-03-28 2009-10-01 Pacific Biosciences Of California, Inc. Methods and compositions for nucleic acid sample preparation
WO2009120372A2 (en) * 2008-03-28 2009-10-01 Pacific Biosciences Of California, Inc. Compositions and methods for nucleic acid sequencing
US20090270273A1 (en) * 2008-04-21 2009-10-29 Complete Genomics, Inc. Array structures for nucleic acid detection
FR2934595B1 (en) * 2008-07-29 2013-04-05 Biomerieux Sa MARKING REAGENTS HAVING A PYRIDINE CORE HAVING DIAZOMETHYL FUNCTION, METHODS FOR SYNTHESIZING SUCH REAGENTS AND METHODS FOR DETECTING BIOLOGICAL MOLECULES
AU2009325069B2 (en) * 2008-12-11 2015-03-19 Pacific Biosciences Of California, Inc. Classification of nucleic acid templates
US20230148447A9 (en) 2008-12-11 2023-05-11 Pacific Biosciences Of California, Inc. Classification of nucleic acid templates
US9175338B2 (en) 2008-12-11 2015-11-03 Pacific Biosciences Of California, Inc. Methods for identifying nucleic acid modifications
FR2940805B1 (en) 2009-01-05 2015-10-16 Biomerieux Sa METHOD FOR AMPLIFYING AND / OR DETECTING NUCLEIC ACIDS, KITS AND USES THEREOF
US8685648B2 (en) 2009-02-03 2014-04-01 Biohelix Corporation Endonuclease-enhanced helicase-dependent amplification
WO2010126614A2 (en) 2009-04-30 2010-11-04 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers
US9524369B2 (en) 2009-06-15 2016-12-20 Complete Genomics, Inc. Processing and analysis of complex nucleic acid sequence data
FR2950358B1 (en) 2009-09-18 2015-09-11 Biomerieux Sa SIMPLIFIED NUCLEIC ACID AMPLIFICATION DEVICE AND METHOD FOR IMPLEMENTING THE SAME
US8951733B2 (en) 2009-10-16 2015-02-10 Monsanto Technology Llc Methods of polynucleotide detection
US8394589B2 (en) 2009-12-21 2013-03-12 Northwestern University Methods for diagnosing scapuloperoneal spinal muscular atrophy or Charcot-Marie-Tooth disease type 2C by detecting mutations in TRPV4
CN103270173B (en) 2010-10-12 2017-11-21 孟山都技术公司 Bean plant and seed and its detection method corresponding to transgenic event MON87712
US10233501B2 (en) 2010-10-19 2019-03-19 Northwestern University Biomarkers predictive of predisposition to depression and response to treatment
US20150225792A1 (en) 2014-01-17 2015-08-13 Northwestern University Compositions and methods for identifying depressive disorders
US10093981B2 (en) 2010-10-19 2018-10-09 Northwestern University Compositions and methods for identifying depressive disorders
US20150218639A1 (en) 2014-01-17 2015-08-06 Northwestern University Biomarkers predictive of predisposition to depression and response to treatment
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
ES2686309T3 (en) 2011-02-02 2018-10-17 Exact Sciences Development Company, Llc Digital sequence analysis of DNA methylation
ES2773692T3 (en) 2011-05-12 2020-07-14 Exact Sciences Corp Nucleic acid isolation
US8808990B2 (en) 2011-05-12 2014-08-19 Exact Sciences Corporation Serial isolation of multiple DNA targets from stool
US8993341B2 (en) 2011-05-12 2015-03-31 Exact Sciences Corporation Removal of PCR inhibitors
MX360940B (en) 2011-06-30 2018-11-21 Monsanto Technology Llc Alfalfa plant and seed corresponding to transgenic event kk 179-2 and methods for detection thereof.
HUE038608T2 (en) * 2011-08-24 2018-10-29 Grifols Therapeutics Llc Compositions and methods for nucleic acid hybridization
EP3225698B1 (en) * 2011-09-06 2019-07-31 Gen-Probe Incorporated Closed nucleic acid structures
WO2013036668A1 (en) * 2011-09-06 2013-03-14 Gen-Probe Incorporated Circularized templates for sequencing
US9228233B2 (en) 2011-10-17 2016-01-05 Good Start Genetics, Inc. Analysis methods
JP6093498B2 (en) 2011-12-13 2017-03-08 株式会社日立ハイテクノロジーズ Nucleic acid amplification method
US9404147B2 (en) 2011-12-19 2016-08-02 Gen-Probe Incorporated Closed nucleic acid structures
EP3269820A1 (en) 2011-12-22 2018-01-17 Ibis Biosciences, Inc. Kit for the amplification of a sequence from a ribonucleic acid
US9528107B2 (en) * 2012-01-31 2016-12-27 Pacific Biosciences Of California, Inc. Compositions and methods for selection of nucleic acids
US8209130B1 (en) 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
JP6172640B2 (en) * 2012-04-12 2017-08-02 国立大学法人 東京大学 Nucleic acid quantification method, detection probe, detection probe set, and nucleic acid detection method
WO2013163207A1 (en) 2012-04-24 2013-10-31 Pacific Biosciences Of California, Inc. Identification of 5-methyl-c in nucleic acid templates
JP6445426B2 (en) 2012-05-10 2018-12-26 ザ ジェネラル ホスピタル コーポレイション Method for determining nucleotide sequence
US9212392B2 (en) 2012-09-25 2015-12-15 Exact Sciences Corporation Normalization of polymerase activity
JP6557151B2 (en) 2013-02-20 2019-08-14 エモリー ユニバーシティー Method for sequencing nucleic acids in a mixture and compositions related thereto
US9623409B2 (en) 2013-03-11 2017-04-18 Cue Inc. Cartridges, kits, and methods for enhanced mixing for detection and quantification of analytes
KR102435654B1 (en) 2013-03-11 2022-08-25 큐 헬스 인코퍼레이티드 Systems and methods for detection and quantification of analytes
US10545161B2 (en) 2013-03-11 2020-01-28 Cue Health Inc. Systems and methods for detection and quantification of analytes
ES2712798T3 (en) 2013-03-14 2019-05-14 Exact Sciences Dev Co Llc Detection of neoplasms
EP2971159B1 (en) 2013-03-14 2019-05-08 Molecular Loop Biosolutions, LLC Methods for analyzing nucleic acids
US10450595B2 (en) 2013-03-15 2019-10-22 Theranos Ip Company, Llc Nucleic acid amplification
CN111378568A (en) 2013-09-06 2020-07-07 赛拉诺斯知识产权有限责任公司 Systems and methods for detecting infectious diseases
US9828599B2 (en) 2013-09-18 2017-11-28 General Electric Company Methods of selecting binding-elements and uses thereof
US20150232931A1 (en) 2013-09-20 2015-08-20 The Regents Of The University Of Michigan Compositions and methods for the analysis of radiosensitivity
US10359419B2 (en) 2013-10-02 2019-07-23 General Electric Company Methods for detection of target using affinity binding
EP3502127B1 (en) 2013-10-09 2023-07-26 Monsanto Technology LLC Transgenic corn event mon87403 and methods for detection thereof
US10851414B2 (en) 2013-10-18 2020-12-01 Good Start Genetics, Inc. Methods for determining carrier status
US10253358B2 (en) 2013-11-04 2019-04-09 Exact Sciences Development Company, Llc Multiple-control calibrators for DNA quantitation
GB201321123D0 (en) 2013-11-29 2014-01-15 Linea Ab Q Amplification of circular molecules
US9909181B2 (en) 2013-12-13 2018-03-06 Northwestern University Biomarkers for post-traumatic stress states
US10138524B2 (en) 2013-12-19 2018-11-27 Exact Sciences Development Company, Llc Synthetic nucleic acid control molecules
WO2015112974A1 (en) 2014-01-27 2015-07-30 The General Hospital Corporation Methods of preparing nucleic acids for sequencing
EP4234722A3 (en) 2014-03-31 2023-09-20 Mayo Foundation for Medical Education and Research Detecting colorectal neoplasm
WO2015175530A1 (en) 2014-05-12 2015-11-19 Gore Athurva Methods for detecting aneuploidy
USD745423S1 (en) 2014-05-12 2015-12-15 Cue Inc. Automated analyzer test cartridge and sample collection device for analyte detection
WO2016040446A1 (en) 2014-09-10 2016-03-17 Good Start Genetics, Inc. Methods for selectively suppressing non-target sequences
US10429399B2 (en) 2014-09-24 2019-10-01 Good Start Genetics, Inc. Process control for increased robustness of genetic assays
CA3183545A1 (en) 2014-12-12 2016-06-16 Exact Sciences Corporation Compositions and methods for performing methylation detection assays
EP3230476B1 (en) 2014-12-12 2020-02-05 Exact Sciences Development Company, LLC Zdhhc1 for normalizing methylation detection assays
EP4095261A1 (en) * 2015-01-06 2022-11-30 Molecular Loop Biosciences, Inc. Screening for structural variants
WO2016160454A1 (en) 2015-03-27 2016-10-06 Exact Sciences Corporation Detecting esophageal disorders
US20180163259A1 (en) 2015-05-01 2018-06-14 Gen-Probe Incorporated Multiplex invasive cleavage assays
US11015217B2 (en) 2015-05-29 2021-05-25 Roche Molecular Systems, Inc. Method of inactivating microbes by citraconic anhydride
CA3224549A1 (en) 2015-07-17 2017-01-26 Cue Health Inc. Systems and methods for enhanced detection and quantification of analytes
EP3998353A1 (en) 2015-10-30 2022-05-18 Exact Sciences Corporation Multiplex amplification detection assay and isolation and detection of dna from plasma
US11008608B2 (en) 2016-02-26 2021-05-18 The Board Of Trustees Of The Leland Stanford Junior University Multiplexed single molecule RNA visualization with a two-probe proximity ligation system
KR102436270B1 (en) 2016-05-05 2022-08-25 이그젝트 싸이언스 디블롭먼트 컴패니, 엘엘씨 Detection of lung tumors by methylated DNA analysis
US20170321286A1 (en) 2016-05-05 2017-11-09 Exact Sciences Corporation Detection of lung neoplasia by amplification of rna sequences
EP3978624A1 (en) 2016-07-19 2022-04-06 Exact Sciences Corporation Methylated control dna
ES2963227T3 (en) 2016-07-19 2024-03-26 Exact Sciences Corp Nucleic acid control molecules of non-human organisms
EP3507298B1 (en) 2016-09-02 2023-08-30 Mayo Foundation for Medical Education and Research Detecting hepatocellular carcinoma
CA3037190A1 (en) 2016-09-15 2018-03-22 ArcherDX, Inc. Methods of nucleic acid sample preparation for analysis of cell-free dna
AU2017328950B2 (en) 2016-09-15 2023-09-14 Archerdx, Llc Methods of nucleic acid sample preparation
US11237161B2 (en) 2017-01-25 2022-02-01 Cue Health Inc. Systems and methods for enhanced detection and quantification of analytes
US11118228B2 (en) 2017-01-27 2021-09-14 Exact Sciences Development Company, Llc Detection of colon neoplasia by analysis of methylated DNA
JP7026248B2 (en) * 2017-11-21 2022-02-25 4ベースバイオ ソシエダー リミターダ Methods and kits for amplifying double-stranded DNA
US10648025B2 (en) 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II
AU2019247652A1 (en) 2018-04-02 2020-10-15 Enumera Molecular, Inc. Methods, systems, and compositions for counting nucleic acid molecules
US11408030B2 (en) 2018-09-10 2022-08-09 Andy Madrid Test for detecting Alzheimer's disease
WO2020206170A1 (en) 2019-04-02 2020-10-08 Progenity, Inc. Methods, systems, and compositions for counting nucleic acid molecules
US11702704B2 (en) 2019-10-31 2023-07-18 Mayo Foundation For Medical Education And Research Detecting ovarian cancer
CA3173798A1 (en) 2020-03-03 2021-09-10 Pacific Biosciences Of California, Inc. Methods and compositions for sequencing double stranded nucleic acids
KR20230049122A (en) 2020-08-19 2023-04-12 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 Detection of non-Hodgkin's lymphoma
EP4214243A1 (en) 2020-09-21 2023-07-26 Progenity, Inc. Compositions and methods for isolation of cell-free dna
WO2023011660A1 (en) 2021-08-06 2023-02-09 Sansure Biotech Inc. Compositions for liquefying a viscous biological sample, combination products, liquefying agents, and kits thereof, and methods and application thereof
WO2024039652A1 (en) 2022-08-16 2024-02-22 Aldevron, L.L.C. Cell-free method of producing synthetic circular nucleic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556750A (en) 1989-05-12 1996-09-17 Duke University Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems
US5712126A (en) * 1995-08-01 1998-01-27 Yale University Analysis of gene expression by display of 3-end restriction fragments of CDNA
EP1114184A2 (en) * 1998-09-15 2001-07-11 Yale University Molecular cloning using rolling circle amplification

Cited By (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615625B2 (en) 1992-08-04 2009-11-10 Replicon, Inc. In vitro amplification of nucleic acid molecules via circular replicons
US20040191816A1 (en) * 1992-08-04 2004-09-30 Replicon, Inc. In vitro amplification of nucleic acid molecules via circular replicons
US20080305535A1 (en) * 1992-08-04 2008-12-11 Replicon, Inc. In vitro amplification of nucleic acid molecules via circular replicons
US6924104B2 (en) 2000-10-27 2005-08-02 Yale University Methods for identifying genes associated with diseases or specific phenotypes
US20020150919A1 (en) * 2000-10-27 2002-10-17 Sherman Weismann Methods for identifying genes associated with diseases or specific phenotypes
US20030104431A1 (en) * 2001-07-15 2003-06-05 Keck Graduate Institute Nucleic acid amplification using nicking agents
US20030152952A1 (en) * 2001-07-15 2003-08-14 Keck Graduate Institute Methylation analysis using nicking agents
US6884586B2 (en) 2001-07-15 2005-04-26 Keck Graduate Institute Methylation analysis using nicking agents
US7112423B2 (en) 2001-07-15 2006-09-26 Keck Graduate Institute Nucleic acid amplification using nicking agents
WO2003044229A1 (en) * 2001-11-20 2003-05-30 Mats Gullberg Nucleic acid enrichment
US8053188B2 (en) 2001-11-20 2011-11-08 Olink Ab Nucleic acid enrichment
US8003322B2 (en) 2007-10-11 2011-08-23 Samsung Electronics Co., Ltd. Method of amplifying a target nucleic acid by rolling circle amplification
US8278051B2 (en) 2007-10-11 2012-10-02 Samsung Electronics Co., Ltd. Method of amplifying a target nucleic acid by rolling circle amplification
EP2048248A1 (en) * 2007-10-11 2009-04-15 Samsung Electronics Co., Ltd. Method of amplifying a target nucleic acid by rolling circle amplification
US20090098612A1 (en) * 2007-10-11 2009-04-16 Samsung Electronics Co., Ltd. Method of amplifying a target nucleic acid by rolling circle amplification
EP2304044A1 (en) * 2008-07-08 2011-04-06 General Electric Company Method and kits for repairing nucleic acid sequences
US9574183B2 (en) 2008-07-08 2017-02-21 General Electric Company Method and kits for repairing nucleic acid sequences
US20100009411A1 (en) * 2008-07-08 2010-01-14 General Electric Company Method and Kits for Repairing Nucleic Acid Sequences
EP2304044A4 (en) * 2008-07-08 2012-03-14 Gen Electric Method and kits for repairing nucleic acid sequences
US11676682B1 (en) 2008-11-07 2023-06-13 Industrial Technology Research Institute Methods for accurate sequence data and modified base position determination
EP2740806A3 (en) * 2008-11-07 2014-08-20 Industrial Technology Research Institute Methods for accurate sequence data and modified base position determination
US10515714B2 (en) 2008-11-07 2019-12-24 Industrial Technology Research Institute Methods for accurate sequence data and modified base position determination
US9767251B2 (en) 2008-11-07 2017-09-19 Industrial Technology Research Institute Methods for accurate sequence data and modified base position determination
US9747414B2 (en) 2008-11-07 2017-08-29 Industrial Technology Research Institute Methods for accurate sequence data and modified base position determination
US11459606B2 (en) 2009-01-30 2022-10-04 Oxford Nanopore Technologies Plc Adaptors for nucleic acid constructs in transmembrane sequencing
US11352664B2 (en) 2009-01-30 2022-06-07 Oxford Nanopore Technologies Plc Adaptors for nucleic acid constructs in transmembrane sequencing
WO2011120046A3 (en) * 2010-03-26 2012-03-08 Swift Biosciences, Inc. Methods and compositions for isolating polynucleotides
WO2011120046A2 (en) * 2010-03-26 2011-09-29 Swift Biosciences, Inc. Methods and compositions for isolating polynucleotides
US20130344485A1 (en) * 2010-12-07 2013-12-26 Gnubio, Inc. Nucleic acid target detection using a detector, a probe and an inhibitor
US10533212B2 (en) 2010-12-07 2020-01-14 Bio-Rad Laboratories, Inc. Nucleic acid target detection using a detector, a probe and an inhibitor
US9581549B2 (en) * 2010-12-07 2017-02-28 Gnubio, Inc. Nucleic acid target detection using a detector, a probe and an inhibitor
US11168363B2 (en) * 2011-07-25 2021-11-09 Oxford Nanopore Technologies Ltd. Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
US11261487B2 (en) 2011-07-25 2022-03-01 Oxford Nanopore Technologies Plc Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
US20200024655A1 (en) * 2011-07-25 2020-01-23 Oxford Nanopore Technologies Ltd. Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
US10851409B2 (en) 2011-07-25 2020-12-01 Oxford Nanopore Technologies Ltd. Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
US20130280713A1 (en) * 2012-04-20 2013-10-24 Samsung Electronics Co., Ltd. Polynucleotide and use thereof
US9193994B2 (en) * 2012-04-20 2015-11-24 Samsung Electronics Co., Ltd. Polynucleotide and use thereof
US11155860B2 (en) 2012-07-19 2021-10-26 Oxford Nanopore Technologies Ltd. SSB method
JP2014100144A (en) * 2012-11-19 2014-06-05 Samsung Electronics Co Ltd Polynucleotide and use thereof
US20140141418A1 (en) * 2012-11-19 2014-05-22 Samsung Electronics Co., Ltd. Polynucleotide and use thereof
US9657345B2 (en) * 2012-11-19 2017-05-23 Samsung Electronics Co., Ltd. Polynucleotide and use thereof
US11560589B2 (en) 2013-03-08 2023-01-24 Oxford Nanopore Technologies Plc Enzyme stalling method
EP3587592A1 (en) * 2013-03-15 2020-01-01 Theranos IP Company, LLC Nucleic acid amplification
US11603558B2 (en) 2013-03-15 2023-03-14 Labrador Diagnostics Llc Nucleic acid amplification
US10745745B2 (en) 2013-03-15 2020-08-18 Labrador Diagnostics Llc Nucleic acid amplification
US11254960B2 (en) 2013-03-15 2022-02-22 Labrador Diagnostics Llc Nucleic acid amplification
US11649487B2 (en) 2013-03-15 2023-05-16 Labrador Diagnostics Llc Nucleic acid amplification
EP2970961A4 (en) * 2013-03-15 2016-12-21 Theranos Inc Nucleic acid amplification
US20150037843A1 (en) * 2013-07-31 2015-02-05 International Business Machines Corporation Polynucleotide configuration for reliable electrical and optical sensing
US20150038691A1 (en) * 2013-07-31 2015-02-05 International Business Machines Corporation Polynucleotide configuration for reliable electrical and optical sensing
US11186857B2 (en) 2013-08-16 2021-11-30 Oxford Nanopore Technologies Plc Polynucleotide modification methods
US11542551B2 (en) 2014-02-21 2023-01-03 Oxford Nanopore Technologies Plc Sample preparation method
RU2616279C1 (en) * 2015-12-28 2017-04-13 Федеральное государственное бюджетное учреждение науки Институт биохимии и генетики Уфимского научного центра Российской академии наук (ИБГ УНЦ РАН) Method for production of marker ladders for gel electrophoretic determination of nucleic acid fragment sizes
US11649480B2 (en) 2016-05-25 2023-05-16 Oxford Nanopore Technologies Plc Method for modifying a template double stranded polynucleotide
CN110643680A (en) * 2016-05-27 2020-01-03 深圳市海普洛斯生物科技有限公司 Linker suitable for ultramicro DNA sequencing and application thereof
US11725205B2 (en) 2018-05-14 2023-08-15 Oxford Nanopore Technologies Plc Methods and polynucleotides for amplifying a target polynucleotide

Also Published As

Publication number Publication date
US20020076704A1 (en) 2002-06-20
US6576448B2 (en) 2003-06-10
US6235502B1 (en) 2001-05-22

Similar Documents

Publication Publication Date Title
US6235502B1 (en) Methods for selectively isolating DNA using rolling circle amplification
US6372434B1 (en) Methods for reducing the complexity of DNA sequences
US6815167B2 (en) Amplification of DNA to produce single-stranded product of defined sequence and length
EP2814986B1 (en) Method for relative quantification of nucleic acid sequence, expression, or copy changes, using combined nuclease, ligation, and polymerase reactions
US7014994B1 (en) Coupled polymerase chain reaction-restriction-endonuclease digestion-ligase detection reaction process
JP5624044B2 (en) Improved allele-specific amplification
EP1712618B1 (en) Method of amplifying nucleic acid and method of detecting mutated nucleic acid using the same
US7175982B1 (en) Method for the characterization of nucleic acid molecules involving generation of extendible upstream DNA fragments resulting from the cleavage of nucleic acid at an abasic site
EP1130113A1 (en) Multiplex ligation dependent amplification assay
US20090215633A1 (en) High throughput sequence-based detection of snps using ligation assays
AU2329497A (en) Target nucleic acid sequence amplification
US20120245041A1 (en) Base-by-base mutation screening
EP1044281B1 (en) Method for in vitro amplification of circular dna
US8501403B2 (en) Amplification of DNA fragments
US5605824A (en) Composition for hybridizing nucleic acids using single-stranded nucleic acid binding protein
KR20150088772A (en) Method for Amplification Nucleic Acid Using Aelle-Specific Reaction Primers
WO2006098428A1 (en) Method of lessening nonspecific amplification from primer dimer
JP4601830B2 (en) Coupled polymerase chain reaction-restriction endonuclease digestion-ligase detection reaction method
JP2017538429A (en) Allele-specific amplification of nucleic acids using blocking oligonucleotides for wild-type suppression
WO1994017206A1 (en) Method for amplifying nucleic acid sequences
KR102501070B1 (en) Method for detecting difference in reference sequence in target nucleic acid region
US20040048292A1 (en) Dual fidelity erca detection systems
Zirvi Use of thermostable ligase to characterize microsatellite instability

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION